| 4956 |
23 |
Co3O4@Co-Fe oxide double-shelled nanocages |
Detection |
acetylcholinesterase (AChE) |
Color |
0.0008-1 |
mU/mL |
0.0002 |
mU/mL |
|
|
| 4957 |
23 |
Co3O4@Co-Fe oxide double-shelled nanocages |
Detection |
H2O2 |
Color |
0.02 - 600 |
μM |
0.02 |
μM |
|
|
| 4958 |
24 |
core–shell UMOFs@Au NPs |
Cancer therapy |
|
|
|
|
|
|
|
|
| 4961 |
29 |
PDA‐Pt‐CD@RuFc NPs |
Cancer therapy |
|
|
|
|
|
|
|
|
| 4971 |
38 |
Pt@PCN222-Mn |
ROS scavenge |
•O2− |
|
|
|
|
|
|
|
| 4973 |
40 |
MoS2/g-C3N4 HNs |
sulfide ions sensing |
S2- |
Color |
0.1-10 |
μM |
37 |
μM |
|
|
| 4974 |
42 |
Atv/PTP-TCeria NPs |
the sepsis-induced AKI therapy |
ROS |
Unsure |
|
|
|
|
|
|
| 4975 |
44 |
Sm-TCPP-Pt |
generating oxygen for PDT |
H2O2 |
|
|
|
|
|
|
|
| 4976 |
45 |
Au40/γ-CD-MOF |
the property tuning and practical application of metal nanoclusters |
|
Color |
|
|
|
|
|
|
| 4977 |
47 |
CuTA |
ROS scavenge |
•O2− •OH |
|
|
|
|
|
|
|
| 4978 |
49 |
Lipo-OGzyme-AIE |
oxygen generation |
|
|
|
|
|
|
|
|
| 4979 |
52 |
EPL-coated MnO2 nanosheets (EM) |
CAT |
H2O2 |
|
|
|
|
|
|
|
| 4982 |
60 |
Cu2MoS4 (CMS)/Au |
Hypoxia Alleviation |
O2- |
color |
|
|
|
|
|
|
| 4983 |
61 |
Fe3O4-TiO2/rGO (FTG) |
detection and photodegradation of pesticide |
atrazine |
Color |
2-20 |
μg/L |
2.98 |
μg/L |
|
|
| 4985 |
64 |
NCNTs@MoS2 |
Detection of AA |
Ascorbic acid (AA) |
Color |
0.2-80 |
μM |
0.12 |
μM |
|
|
| 4986 |
64 |
NCNTs@MoS2 |
Detection of H2O2 |
H2O2 |
Color |
2–50 |
μM |
0.14 |
μM |
|
|
| 4988 |
68 |
Fe3O4@SiO2-NH2-Au@PdNPs |
Detection of Glucose |
glucose |
Color |
0.010−60 |
μM |
0.06 |
μM |
0.93 |
|
| 4989 |
71 |
Au/Co@HNCF |
identify the low levels of uric acid (UA) in human serum |
uric acid |
E-chem |
0.1–2500 |
μM |
0.023 |
μM |
|
|
| 4991 |
75 |
BDD|PB nanozymes |
utmost sensitivity of the H2O2 sensor |
H2O2 |
E-chem |
1×10-7-1×10-3 |
M |
0.14 ± 0.02 |
A M -1 cm-2 |
|
|
| 4992 |
76 |
DNA-Ag/Pt NCs |
detection of miRNA-21 |
miRNA-21 |
Color |
1-700 |
pM |
0.6 |
pM |
|
|
| 4993 |
77 |
TPP-MoS2 QDs |
mitigate AD pathology |
O2•- •OH H2O2 |
|
|
|
|
|
|
|
| 4996 |
84 |
Co-V MMO nanowires |
Antibacterial |
|
|
|
|
|
|
|
|
| 4997 |
87 |
CeM |
treatment of Alzheimer's disease |
|
|
|
|
|
|
|
|
| 5010 |
106 |
IMSN-PEG-TI |
The results show that IMSN nanozyme exhibits both intrinsic peroxidase-like and catalase-like activities under acidic TME, which can decompose H2O2 into hydroxyl radicals (•OH) and oxygen (O2), respectively |
|
|
|
|
|
|
|
|
| 5014 |
111 |
F-BS NCs |
virus-like F-BS NCs have been successfully constructed by simple ultrasound that possesses PA and IRT imaging capacity, by which synergetic PT and PT-enhanced nanozymatic biocatalytic cancer-combating therapy is hopeful to be realized. |
|
|
|
|
|
|
|
|
| 5017 |
114 |
Pt-carbon nanozyme |
The established Pt-carbon nanozyme enabled us to carry out a simultaneous favorable CAT-like activity and high-efficiency photothermal/photodynamic tumor therapy in near-infrared light. |
|
|
|
|
|
|
|
|
| 5018 |
115 |
CuO-C-dots |
determination of glucose |
glucose |
E-chem |
0.5-2-5 |
mM |
0.2 |
mM |
88%-94% |
|
| 5019 |
117 |
Au/Fe-MOF |
|
prostate specific antigen |
E-chem |
0.001-100 |
ng/mL |
0.13 |
pg/mL |
|
|
| 5020 |
118 |
Au@Au-aptamer |
|
HIF-1α |
Color |
0.3-200 |
ng/L |
0.2 |
ng/L |
97.2-101.3% |
|
| 5022 |
120 |
Fe3O4-Au@Ag |
|
CaMV35S gene |
E-chem |
1x10-16-1x10-10 |
M |
1.26x10-17 |
M |
|
|
| 5023 |
121 |
CeO2/C nanowires |
|
glucose |
Color |
1-100 |
μM |
0.69 |
μM |
|
|
| 5025 |
124 |
PPy@MnO2-BSA |
|
|
|
|
|
|
|
|
T1-MRI-guided combined photothermal therapy (PTT) and photodynamic therapy (PDT) of tumors |
| 5026 |
125 |
Ag@Au core/shell TNPs |
|
glucose |
Color |
1-30 |
mM |
1 |
mM |
90.2-103% |
|
| 5027 |
126 |
Ab2-MSN-PQQ |
|
prostate specific antigen |
Color |
0.005-0.5 |
ng/mL |
1 |
pg/mL |
|
|
| 5028 |
127 |
GOx-MnO2/HMME |
|
|
|
|
|
|
|
|
Magnetic resonance imaging and anti-tumor efficiency in vitro and in vivo |
| 5031 |
129 |
CoFe-LDH/CeO2 |
|
H2O2 |
Color |
0.01-1 |
mM |
0.003 |
mM |
|
|
| 5030 |
129 |
CoFe-LDH/CeO2 |
|
glucose |
Color |
0.05-2 |
mM |
0.015 |
mM |
|
|
| 5032 |
130 |
Ru4PCVs |
|
|
|
|
|
|
|
|
A new type of catalytic micro-compartment with multi-functional activity |
| 5037 |
138 |
Ru@CeO2 YSNs |
Cancer therapy |
|
|
|
|
|
|
|
|
| 5038 |
139 |
AuNFs/Fe3O4@ZIF-8-MoS2 |
Electrochemical detection of H2O2 released from cells |
H2O2 |
E-chem |
5-15000 |
μM |
0.9 |
μM |
|
|
| 5039 |
139 |
AuNFs/Fe3O4@ZIF-8-MoS2 |
Electrochemical detection of H2O2 released from cells |
H2O2 |
E-chem |
15-120 |
mM |
0.9 |
μM |
|
One was from 5 μM to 15 mM with a linear regression equation of I(μA) = 0.0171C(μM) + 16.6 (R2 = 0.990) (Fig. 4d), and the other was from 15 mM to 120 mM with a linear regression equation of I(μA) = 0.00417C(μM) + 191 (R2 = 0.993) (Fig. 4e). The reason for two linear regions was probably caused by the different H2O2 absorption and activation behavior on AuNFs/Fe3O4@ZIF-8-MoS2 hybrid catalyst under different H2O2 concentration [4]. |
| 5041 |
141 |
CDAu |
detection of Pb(II) |
Pb(II) |
Color |
0.0005–0.46 |
μM |
0.25 |
nM |
|
|
| 5042 |
141 |
CDAu |
detection of Pb(II) |
Pb(II) |
Color |
0.0005–0.46 |
μM |
0.25 |
nM |
|
Thus, a new and highly sensitive synergetic catalytic fluorescence method for the determination of 0.0005–0.46 μmol/L Pb(II) was established, with a detection limit of 0.25 nmol/L, |
| 5046 |
145 |
Ag/ZnMOF |
detection of bleomycin |
bleomycin |
E-chem |
0.5-500 |
nM |
0.18 |
nM |
|
|
| 5045 |
145 |
Ag/ZnMOF |
detection of bleomycin |
bleomycin |
E-chem |
0.5-500 |
nM |
0.18 |
nM |
|
Photoelectrochemical |
| 5047 |
147 |
Fe3O4@Cu/GMP |
pollutant removal |
|
|
|
|
|
|
|
|
| 5048 |
148 |
AgNP@CD |
Detection of H2O2 and Glucose |
Glucose |
Color |
1-600 |
μM |
10 |
nM |
|
|
| 5049 |
148 |
AgNP@CD |
Detection of H2O2 and Glucose |
H2O2 |
Color |
0.01-9 |
μM |
9 |
nM |
|
|
| 5055 |
154 |
GOD/hPB@gellan |
Cancer therapy |
|
|
|
|
|
|
|
|
| 5057 |
156 |
Au@NH2-MIL-125(Ti) |
Colorimetric detection of H2O2 and cysteine |
H2O2 |
Color |
2–10 |
μM |
0.24 |
μM |
|
|
| 5058 |
156 |
Au@NH2-MIL-125(Ti) |
Colorimetric detection of Hg2+ |
Hg2+ |
Color |
1-5 |
μM |
0.1 |
μM |
104.1±3.03 |
|
| 5059 |
156 |
Au@NH2-MIL-125(Ti) |
Colorimetric detection of Hg2+ |
cysteine |
Color |
1–10 |
μM |
0.14 |
μM |
93.8±3.23 |
|
| 5060 |
156 |
Au@NH2-MIL-125(Ti) |
Colorimetric detection of Hg2+ |
Hg2+ |
Color |
1-5 |
μM |
0.1 |
μM |
104.1±3.03 |
104.1±3.03 at 3μM; 91.56±2.03 at 6μM; 106.9±2.53 μM |
| 5061 |
156 |
Au@NH2-MIL-125(Ti) |
Colorimetric detection of Hg2+ |
cysteine |
Color |
1–10 |
μM |
0.14 |
μM |
93.8±3.23 |
93.8±3.23 at4.0 μM; 100.3 ±5.62 at 7.0 μM; 103.5±6.13 at 9.0 μM |
| 5062 |
157 |
PEG/Ce-Bi@DMSN |
in vitro photothermal-enhanced nanocatalytic therapeutic efficacy |
|
|
|
|
|
|
|
|
| 5067 |
161 |
CeO2/Mn3O4 Nanocrystals |
Epitaxially Strained CeO2 /Mn3 O4 Nanocrystals as an Enhanced Antioxidant for Radioprotection |
|
|
|
|
|
|
|
|
| 5068 |
162 |
Ir@MnFe2O4 NPs |
A mitochondria-targeting magnetothermogenic nanozyme for magnetinduced synergistic cancer therapy |
|
|
|
|
|
|
|
|
| 5069 |
162 |
Ir@MnFe2O4 NPs |
A mitochondria-targeting magnetothermogenic nanozyme for magnetinduced synergistic cancer therapy |
|
|
|
|
|
|
|
antitumor |
| 5075 |
167 |
UsAuNPs/MOFs |
H2O2 is widely used in the treatment of bacterial infections. However, compared with H2O2, hydroxyl radicals are much more reactive and can cause more serious oxidative damages to bacteria.[37] Given the excellent POD-like activity of the prepared UsAuNPs/MOFs, the in vitro antimicrobial activities against Staphylococcus aureus and Escherichia coli were evaluated in the presence of H2O2. |
|
|
|
|
|
|
|
|
| 5079 |
169 |
FeTPP assemblies within AuTTMA monolayer |
The catalytic properties of the nanozymes were studied in PBS buffer through the activation of a nonfluorescent resorufin-based profluorophore (pro-Res, Figure 1B), wherereduction of theazide resultsinfragmentation and release of the fluorescent resorufin molecule |
|
|
|
|
|
|
|
|
| 5081 |
172 |
Fe3O4@PDA@BSA-Bi2S3 |
a Fe3O4@PDA@BSA-Bi2S3 composite theranostic agent was successfully prepared for synergistic tumor PTT and CDT, in which the BSA coating endows the NPs with colloidal stability and both in vitro and in vivo biocompatibility. |
|
|
|
|
|
|
|
|
| 5083 |
174 |
IrRu-GOx@PEG NPs |
Iridium/ruthenium nanozyme reactors with cascade catalytic ability for synergistic oxidation therapy and starvation therapy in the treatment of breast cancer |
|
|
|
|
|
|
|
|
| 5084 |
175 |
Fe3O4/CoFe-LDH |
A sensitively and selectively visual sensor for the determination of ascorbic acid (AA) was successfully constructed based on the reduction effect of AA with enediol group on the formed oxidation of TMB |
Ascorbic acid (AA) |
Color |
0.5-10 |
μM |
0.2 |
μM |
98.3%-101.3% |
|
| 5091 |
181 |
hemin@CD |
a colorimetric and fluorescent dual-channel sensor for H2O2, glucose and xanthine was developed, and the results are satisfied in the application of real samples |
glucose |
Fluor |
0.17–133 |
μM |
0.15 |
μM |
92.2%～105.6% |
|
| 5092 |
181 |
hemin@CD |
a colorimetric and fluorescent dual-channel sensor for H2O2, glucose and xanthine was developed, and the results are satisfied in the application of real samples |
xanthine |
Fluor |
0.17–33 |
μM |
0.12 |
μM |
98.8-103.6% |
|
| 5093 |
181 |
hemin@CD |
a colorimetric and fluorescent dual-channel sensor for H2O2, glucose and xanthine was developed, and the results are satisfied in the application of real samples |
xanthine |
Color |
0.17–33 |
μM |
0.15 |
μM |
93.4-102.4% |
|
| 5094 |
181 |
hemin@CD |
a colorimetric and fluorescent dual-channel sensor for H2O2, glucose and xanthine was developed, and the results are satisfied in the application of real samples |
H2O2 |
Fluor |
0.17–133 |
μM |
0.15 |
μM |
|
|
| 5095 |
181 |
hemin@CD |
a colorimetric and fluorescent dual-channel sensor for H2O2, glucose and xanthine was developed, and the results are satisfied in the application of real samples |
glucose |
Color |
0.17–133 |
μM |
0.15 |
μM |
92.2%～105.6% |
|
| 5096 |
181 |
hemin@CD |
a colorimetric and fluorescent dual-channel sensor for H2O2, glucose and xanthine was developed, and the results are satisfied in the application of real samples |
H2O2 |
Color |
0.17–133 |
μM |
0.11 |
μM |
|
|
| 5098 |
183 |
GCE/MWCNTs-Av/RuNPs |
highly sensitive quantification of H2O2. |
H2O2 |
E-chem |
0.5—1750 |
μM |
65 |
Nm |
|
|
| 5099 |
183 |
GCE/MWCNTs-Av/RuNPs/biot-Gox |
a highly sensitive pseudo-bienzymatic glucose biosensor. |
glucose |
E-chem |
20—1230 |
μM |
3.3 |
μM |
|
|
| 5100 |
184 |
DNA/GO–PtNPs |
detection of nucleic acids |
MicroRNA |
Color |
0.05-10 |
nM |
21.7 |
pM |
|
|
| 5101 |
184 |
DNA/GO–PtNPs |
detection of nucleic acids |
KRAS Gene |
Color |
0.025-5 |
nM |
14.6 |
pM |
|
|
| 5102 |
186 |
mGPB |
a multi-enzyme system (mGPB) with self-sufficient H2O2 supply and photoselective multienzyme-like activities was developed for enhanced tumor catalytic therapy |
|
|
|
|
|
|
|
|
| 5103 |
189 |
CC-PdNPs |
detection of iodine ions |
iodine ions |
Color |
0-6.25 |
Nm |
0.19 |
nM |
95.52-102.8% |
|
| 5104 |
190 |
MNET |
remodel the microenvironment of a stroke by self-adapted oxygen regulating and free radical scavenging |
|
|
|
|
|
|
|
|
| 5105 |
193 |
Cu-hNFs |
antibacterial |
|
|
|
|
|
|
|
|
| 5106 |
194 |
aptamer-AuNPs |
determination of CRP in blood |
C-reactive protein (CRP) |
Color |
0.1-200 |
ng/mL |
8 |
pg/mL |
94.54%–98.03% |
|
| 5109 |
199 |
M/H-D |
Enhanced Tumor Penetration and Radiotherapy Sensitization |
|
|
|
|
|
|
|
|
| 5114 |
202 |
2.6Pt/EMT |
Detection of H2O2 and glucose |
H2O2 |
Color |
2.9-29.4 |
μM |
1.1 |
μM |
|
|
| 5113 |
202 |
2.6Pt/EMT |
Detection of H2O2 and glucose |
glucose |
Color |
0.09-0.27 |
mM |
13.2 |
μM |
|
|
| 5115 |
203 |
paper-based sensor |
MiRNA Detection. |
miRNA-141 |
E-chem |
0.002-170 |
pM |
0.6 |
fM |
97.0–110.0% |
|
| 5116 |
203 |
paper-based sensor |
MiRNA Detection. |
miRNA-141 |
E-chem |
0.002-170 |
pM |
0.6 |
fM |
97.0–110.0% |
the recoveries and RSD were in the range of 97.0–110.0 and 1.31–13.64%, suggesting a gratifying analysis capability of the proposed sensor for miRNA-141 in complex clinical samples. |
| 5130 |
217 |
IrO2/GO |
detection of AA |
Ascorbic acid (AA) |
Color |
5-70 |
Nm |
324 |
nM |
|
|
| 5129 |
217 |
IrO2/GO |
detection of AA |
Ascorbic acid (AA) |
Color |
5-70 |
Nm |
324 |
nM |
|
The corresponding absorbance exhibited good linearity to the concentration of AA in the range of 5–70 μM with a coefficient of determination (R2) equal to 0.9931 |
| 5131 |
220 |
MoS2@CGTC NCR |
MoS2@CGTC NCR achieves glucose-responsive TME self-modulation for enhanced cascaded chemo-catalytic therapy of tumors. |
|
|
|
|
|
|
|
MoS2@CGTC NCR achieves glucose-responsive TME self-modulation for enhanced cascaded chemo-catalytic therapy of tumors. |
| 5132 |
220 |
MoS2@CGTC NCR |
MoS2@CGTC NCR achieves glucose-responsive TME self-modulation for enhanced cascaded chemo-catalytic therapy of tumors. |
|
|
|
|
|
|
|
|
| 5133 |
221 |
VB2-IONzymes |
mouth ulcer healing |
|
|
|
|
|
|
|
|
| 5134 |
222 |
Hg2+/heparin–OsNPs |
detection of heparinase in human serum samples |
heparinase |
Color |
20-1000 |
μg L-1 |
15 |
μg L-1 |
|
|
| 5135 |
223 |
laccase@MMOFs |
industrial dye degradation |
|
|
|
|
|
|
|
|
| 5141 |
229 |
lipase immobilized on Fe3O4/SiO2/Gr NC |
|
|
|
|
|
|
|
|
This material can not belong to nanozyme. It is synthesized by immobolize the natural lipase on the nanomaterials framework. |
| 5142 |
230 |
HP-HIONs@PDA-PEG |
tumor therapy via modulating reactive oxygen species and heat shock proteins |
|
|
|
|
|
|
|
|
| 5146 |
235 |
GOx&PVI-Hemin@ZIF-8 |
enhanced cascade catalysis to detect glucose |
glucose |
Color |
0-200 |
μM |
0.4 |
μM |
|
|
| 5147 |
257 |
TiO2/C-QDs |
GSH detection |
GSH |
Color |
0.5-25 |
μM |
0.2 |
μM |
|
|
| 5148 |
257 |
TiO2/C-QDs |
GSH detection |
GSH |
Color |
0.5-25 |
μM |
0.2 |
μM |
|
taking human serum as an example, the possibility of applying GSH colorimetry to actual biological samples wasexamined by standard addition methods. |
| 5149 |
258 |
RBIR |
for single-wavelength laser activated photothermal-photodynamic synergistic treatment against hypoxic tumors |
|
|
|
|
|
|
|
|
| 5153 |
261 |
Co–Fe@hemin |
Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen |
|
CL |
0.2-100 |
ng/mL |
0.1 |
ng/mL |
|
|
| 5158 |
268 |
Fe3O4@Au MBs |
aptasensor for detection of aflatoxin B1 |
Aflatoxin B1 |
Color |
5-200 |
ng/mL |
35 |
pg/mL |
|
|
| 5163 |
272 |
ICG-PtMGs@HGd |
Persistent Regulation of Tumor Hypoxia Microenvironment via a Bioinspired Pt-Based Oxygen Nanogenerator for Multimodal Imaging-Guided Synergistic Phototherapy |
|
|
|
|
|
|
|
|
| 5166 |
275 |
GO-CTAB-AuNP-hemin nanozymes |
Colorimetric apta-biosensing of amphetamin and methamphetamin |
methamphetamin |
|
0.5–100 |
μM |
154 |
nM |
|
|
| 5167 |
275 |
GO-CTAB-AuNP-hemin nanozymes |
Colorimetric apta-biosensing of amphetamin and methamphetamin |
methamphetamin |
|
0.5–100 |
μM |
154 |
nM |
|
MAMP detection in mixed drug samples was investigated |
| 5168 |
275 |
GO-CTAB-AuNP-hemin nanozymes |
Quantitative detection of amphetamin and methamphetamin |
amphetamin |
|
0.5–100 |
μM |
185 |
nM |
|
detection and quantitation of AMP in a seized drug sample were performed |
| 5169 |
275 |
GO-CTAB-AuNP-hemin nanozymes |
Quantitative detection of amphetamin and methamphetamin |
amphetamin |
|
0.5–100 |
μM |
185 |
nM |
|
|
| 5170 |
276 |
HRP@MOFs composite |
biomacromolecule embedding with excellent bioactivity |
|
|
|
|
|
|
|
|
| 5171 |
277 |
HIONCs-GOD |
synergistic chemodynamic−hyperthermia therapy |
H2O2 |
|
|
|
|
|
|
|
| 5174 |
281 |
MIL@GOx-MIL NRs |
anti-bacteria |
|
|
|
|
|
|
|
|
| 5178 |
287 |
BM-20 nanosheets |
H2O2 detection |
H2O2 |
Color |
1-1000 |
μM |
0.4 |
μM |
|
|
| 5179 |
288 |
MGCN-chitin-AcOH |
glucose detection |
glucose |
Color |
5-1000 |
μM |
0.055 |
μM |
|
|
| 5185 |
295 |
GO/Au |
diagnosis |
PBP2a |
Color |
20-300 |
nM |
|
|
|
|
| 5188 |
298 |
Cu‐ATP, Cu‐ADP, Cu‐AMP |
a chemical sensor array based on nanozymes was developed to discriminate between different metal ions and teas |
12 metal ions including Sn2+, Fe3+, Cu2+, Ag+, Pb2+, Mg2+, Mn2+, Ca2+, Al3+, Cr2+, Ni+, Ba2+ |
Color |
|
|
0.01 |
μM |
|
|
| 5189 |
300 |
A-III and B-IV |
A-III and B-IV coatings clearly restricted and promoted the spreading of adherent RAW264.7 macrophages, respectively. |
|
|
|
|
|
|
|
|
| 5190 |
301 |
His-GQD/hemin |
detecting H2O2 |
H2O2 |
Color |
5-240 |
μM |
|
|
|
|
| 5191 |
301 |
His-GQD/hemin |
detecting blood glucose |
glucose |
Color |
2.5-200 |
μM |
|
|
|
|
| 5192 |
302 |
MoS2-MIL-101(Fe) |
On the basis, a sensitive method for H2O2 detection was proposed with a linear range of 0.01−20 μmol/L and a detection limit of 10 nmol/L. Considering H2O2 as product in the reaction of glucose catalyzed by glucose oxidase, a sensitive and selective method for glucose detection was proposed. The method can be used in blood glucose detection with good accuracy. |
H2O2 |
Color |
0.01−20 |
μM |
10 |
nM |
|
|
| 5193 |
302 |
MoS2-MIL-101(Fe) |
detecting glucose |
glucose |
Color |
0.01-15 |
μM |
0.01 |
μM |
|
|
| 5194 |
303 |
Quercetin@ZIF-90 (QZ) |
a novel “Off-On” colorimetric method for ATP sensing was established |
ATP |
Color |
2-80 |
μM |
|
|
|
|
| 5195 |
303 |
Quercetin@ZIF-90 (QZ) |
a novel “Off-On” colorimetric method for ATP sensing was established |
ATP |
Color |
2-80 |
μM |
|
|
|
MNs-QZ |
| 5198 |
305 |
Cu-NC |
sensing of AA |
AA |
Color |
5-15 |
μM |
5.4 |
μM |
|
|
| 5201 |
310 |
AuBP@Pt and AuPd-PDA |
Detection of APOE4 |
APOE4 |
E-chem |
0.05-2000 |
ng mL -1 |
15.4 |
pg mL -1 |
|
In conclusion, an ultrasensitive electrochemical immunosensor based on AuBP@Pt nanostructures and AuPd-PDA nanozyme was developed for the detection of APOE4. |
| 5202 |
310 |
AuBP@Pt and AuPd-PDA |
Detection of APOE4 |
APOE4 |
E-chem |
0.05-2000 |
ng mL -1 |
15.4 |
pg mL -1 |
|
|
| 5209 |
318 |
Fe3O4@TAn nanoflowers (NFs) |
In vitro experiments verify that the Fe3O4@TAn NFs demon |
multiple reactive oxygen and nitrogen species |
|
|
|
|
|
|
|
| 5210 |
320 |
Au-BNNs and Ag-BNNs nanohybrids |
|
Our results present new elements regarding BNNs-based nanohybrids which may help expand their applications in various fields such as catalyst, antimicrobial, biomedical, biosensor, and fillers in polymer matrix. |
|
|
|
|
|
|
|
| 5211 |
321 |
PdNPs/GDY |
Our findings demonstrate that the rational design of a nano |
|
|
|
|
|
|
|
|
| 5212 |
322 |
PDI-CeCoO3 |
Based on this, a colorimetric assay for GSH biosensing has been developed. |
GSH |
Color |
1-10 |
M |
0.658 |
μM |
|
|
| 5214 |
323 |
MnFe2O4/g-C3N4 |
An extremely sensitive colorimetric glucose sensor was fabricated using a novel hybrid nanostructure comprised of manganese ferrite oxide– graphitic carbon nitride (MnFe2O4/g-C3N4). |
Glucose |
Color |
100nM-0.1mM/0.1mM-10mM |
|
17.3nM/1.13μM |
|
90.0-105.9% |
|
| 5213 |
323 |
MnFe2O4/g-C3N4 |
|
H2O2 |
Color |
50-100000 |
nM |
20.5 |
nM |
|
|
| 5220 |
327 |
Co4S3/Co3O4 nanotubes |
Antibacteria |
|
|
|
|
|
|
|
|
| 5226 |
333 |
Fe3O4@Au@MIL-100(Fe) |
Dye degradation |
|
|
|
|
|
|
|
|
| 5229 |
334 |
Au/MOFs(Fe, Mn)/CNTs |
Detection of H2O2, glucose and sulfadimethoxine |
H2O2 |
Color |
0.34-53.05 |
nM |
0.18 |
nM |
|
|
| 5227 |
334 |
Au/MOFs(Fe, Mn)/CNTs |
Detection of H2O2, glucose and sulfadimethoxine |
glucose |
Color |
0.005-0.3 |
μM |
0.002 |
μM |
|
doutable |
| 5228 |
334 |
Au/MOFs(Fe, Mn)/CNTs |
Detection of H2O2, glucose and sulfadimethoxine |
H2O2 |
Color |
0.34-53.05 |
nM |
0.18 |
nM |
|
doutable |
| 5230 |
334 |
Au/MOFs(Fe, Mn)/CNTs |
Detection of H2O2, glucose and sulfadimethoxine |
sulfadimethoxine |
Color |
0.54-41.58 |
μg/L |
0.35 |
μg/L |
|
doutable |
| 5231 |
334 |
Au/MOFs(Fe, Mn)/CNTs |
Detection of H2O2, glucose and sulfadimethoxine |
sulfadimethoxine |
Color |
0.54-41.58 |
μg/L |
0.35 |
μg/L |
|
|
| 5232 |
334 |
Au/MOFs(Fe, Mn)/CNTs |
Detection of H2O2, glucose and sulfadimethoxine |
glucose |
Color |
0.005-0.3 |
μM |
0.002 |
μM |
|
|
| 5248 |
343 |
rGO/PEI/Au nanohybrids |
addition of a trace amount of Cr6+, rGO/PEI/Au nanohybrids can effectively catalyze TMB–H2O2 in ultrapure water; thus, a visual chemosensor and electronic spectrum quantitative analysis method for Cr6+ based on chromium-stimulated peroxidase mimetic activity of rGO/PEI/Au nanohybrids were established |
H2O2 |
Color |
|
|
|
|
|
|
| 5257 |
356 |
MoS2/rGO VHS |
excellent antibacterial effect in situ |
|
|
|
|
|
|
|
not only develops a new protocol to construct efficient nanozymes with capturing ability, as alternative antibiotics, but also provides new insight into the smart biomaterials design by defecting chemistry, integrating nanotopology, and catalytic performance |
| 5258 |
356 |
MoS2/rGO VHS |
excellent antibacterial effect in situ |
|
|
|
|
|
|
|
|
| 5261 |
358 |
50Co/CuS-MMT |
detection of H2O2 residue in contact lens solution |
H2O2 |
Color |
10-100 |
μM |
2.2 |
μM |
|
|
| 5262 |
358 |
50Co/CuS-MMT |
detection of H2O2 residue in contact lens solution |
H2O2 |
Color |
10-100 |
μM |
2.2 |
μM |
|
Fig. 6B displays that the absorbance at 652 nm was linearly correlated with H2O2 concentration from 10 to 100 μM and the limit of detection (LOD) was calculated to be 2.2 μM (LOD = 3 s/k, where s, k are the relative standard deviation of eight parallel controlled measurements and the slope of the linear calibration plots, respectively. In this formula, s = 0.000157, k = 2.14 × 10−4, and therefore, LOD =2.2 μM). |
| 5263 |
361 |
CoO@AuPt |
initiate intracellular hemodynamic reactions in response to TME clues |
|
|
|
|
|
|
|
|
| 5275 |
371 |
Mn3O4@Au-dsDNA/DOX |
synergistic antitumor immunotherapy |
|
|
|
|
|
|
|
|
| 5276 |
372 |
Cu2（OH）3NO3 |
detect biothiols in human blood serum |
|
|
|
|
|
|
|
|
| 5277 |
372 |
Cu2（OH）3NO3 |
detect biothiols in human blood serum |
|
|
|
|
|
|
|
On the basis of the oxidase-like catalytic of Cu2(OH)3NO3 nanosheets, a simple, quick, sensitive, and selective colorimetric assay was developed to determine biothiols. More interestingly, this technique was successfully applied to detect biothiols in human blood serum, suggesting it has a hopeful prospect for diagnostic in the relevant application. |
| 5278 |
374 |
AL-PB-600 |
a promising agent in antioxidant therapies |
|
|
|
|
|
|
|
|
| 5286 |
378 |
rGO/CM (6 h) (2:1) |
glucose sensing activity |
|
Color |
1–10 |
μM |
0.15 |
μM |
|
Fig. 5d shows the HR-TEM images of rGO/CM (48 h) nanocomposites where large size (∼500 nm) polyhedrons are attached with rGO sheet. |
| 5284 |
378 |
rGO/CM (6 h) (2:1) |
glucose sensing activity |
|
Color |
1–10 |
μM |
0.15 |
μM |
|
|
| 5285 |
378 |
rGO/CM (6 h) (2:1) |
glucose sensing activity |
glucose |
Color |
1–50 |
μM |
0.43 |
μM |
|
|
| 5290 |
381 |
PdCu TPs/PG |
sensitive detection of HBe Ag |
HBe Ag |
Color |
from 60 fg·mL−1 to 100 ng·mL−1 |
|
20 |
fg·mL−1 |
|
|
| 5296 |
387 |
Ag@Ag2WO4 NRs |
H2O2 and glucose sensing |
H2O2 |
Color |
62.34~2400 |
μM |
6.25 |
μM |
|
|
| 5295 |
387 |
Ag@Ag2WO4 NRs |
H2O2 and glucose sensing |
glucose |
Color |
27.7~300 |
μM |
2.6 |
μM |
|
|
| 5297 |
387 |
Ag@Ag2WO4 NRs |
H2O2 and glucose sensing |
H2O2 |
Color |
62.34~2400 |
μM |
6.25 |
μM |
|
Since Glucose oxidase could be denatured at pH 3.0 acetate buffer solution, glucose detection was realized by the following procedure: 200 μL of glucose with different concentrations in 0.01 M acetate buffer solution (pH 5.0) was prepared with 50 μL of 10 mg mL-1 GOx and incubated at 37 °C for 30 min. This solution was then added to a mixture of 50 μL of 10 mM TMB, 100 μL of 0.5 mg mL-1 Ag2WO4 NRs and 200 μL of 0.1 M acetate buffer (pH 5.0). The mixed solution was incubated at room temperature for 30 min, and used for absorbance measurement at 652 nm. |
| 5303 |
393 |
C‑dots/Mn3O4 nanocomposite |
|
Fe2+ |
Color |
0.03-0.83 |
μM |
0.03 |
μM |
|
|
| 5305 |
394 |
Fe3O4@Cu/C |
To evaluate the peroxidase catalytic performance of Fe3O4@Cu/C and Fe3O4@CuO composites, catalytic experiments were performed toward the oxidative degradation of model organic dyes (MB) |
|
|
|
|
|
|
|
|
| 5304 |
394 |
Fe3O4@CuO |
To evaluate the peroxidase catalytic performance of Fe3O4@Cu/C and Fe3O4@CuO composites, catalytic experiments were performed toward the oxidative degradation of model organic dyes (MB) |
|
|
|
|
|
|
|
|
| 5306 |
395 |
Gold-Mesoporous Silica Heteronanostructures |
Au NPs supported onto mesoporous silica supports via electrostatic attraction represents a feasible and straightforward strategy to fabricate glucose-oxidase enzyme-like inorganic platforms able to deliver a successful performance under mild reaction conditions (neutral pH and temperature). |
|
|
|
|
|
|
|
|
| 5310 |
399 |
GO−Fe(III) |
Selective Photoreduction of Highly Toxic Pollutants |
|
|
|
|
|
|
|
|
| 5311 |
400 |
MS@MnO2 hybrid |
In situ fabrication of MS@MnO2 hybrid as nanozymes for enhancing ROS-mediated breast cancer therap |
|
|
|
|
|
|
|
|
| 5314 |
410 |
Au@HMPB |
Detection protein biomarker |
sCD25 |
E-chem |
10pg/ml-10ng/ml |
|
3 |
pg/mL |
96.2-98.3 |
|
| 5315 |
413 |
MoS2-QDs-AgNPs |
visual determination of cysteine |
cysteine |
Color |
1-100 |
μM |
824 |
nM |
90-109 |
|
| 5317 |
417 |
Fe3O4@MoS2-Ag nanozyme |
antibacterial |
|
|
|
|
|
|
|
|
| 5324 |
421 |
Por-NiCo2S4 |
detect H2O2 and cholesterol with a very low detection limit |
H2O2 |
Color |
0.02-1.0 |
mM |
10.06 |
μM |
|
|
| 5323 |
421 |
Por-NiCo2S4 |
Determination of cholesterol in human serum |
cholesterol |
Color |
0.1-9 |
mM |
19.36 |
μM |
|
|
| 5326 |
422 |
BSA-PtNP@MnCo2O4 |
biosensing of glutathione |
GSH |
Color |
1-10 |
μM |
0.42 |
μM |
|
|
| 5325 |
422 |
BSA-PtNP@MnCo2O4 |
Determination of glucose |
glucose |
Color |
10-120 |
μM |
8.1 |
μM |
|
|
| 5327 |
423 |
Lyz-AuNPs |
antibacterial |
|
|
|
|
|
|
|
We realise an antibacterial nanomaterial based on the self-limited assembly of patchy plasmonic colloids, obtained by adsorption of lysozyme to gold nanoparticles. |
| 5328 |
423 |
Lyz-AuNPs |
antibacterial |
|
|
|
|
|
|
|
|
| 5329 |
424 |
m-SAP/cDNA |
detection of aflatoxin B1 (AFB1) |
Aflatoxin B1 |
Color |
0.01-1000 |
ng/ml |
5 |
pg/ml |
0.042000000000000003 |
|
| 5331 |
427 |
BMH Hydrogel |
simultaneous melanoma therapy and multidrug-resistant bacteria-infected wound healing |
|
|
|
|
|
|
|
|
| 5332 |
427 |
BMH Hydrogel |
simultaneous melanoma therapy and multidrug-resistant bacteria-infected wound healing |
|
|
|
|
|
|
|
we developed an injectable redox and light responsive bio-inspired MnO2 hybrid (BMH) hydrogel for effective melanoma photothermo-chemotherapy and MDR bacteria infected-wound healing. |
| 5334 |
428 |
Au–MoS2 nanocomposites |
detection of cadmium |
cadmium |
Color |
1-500 |
ng/ml |
0.7 |
ng/ml |
|
The developed method was successfully applied for the analysis of cadmium ions in white wine samples. |
| 5333 |
428 |
Au–MoS2 nanocomposites |
detection of cadmium |
cadmium |
Color |
1-500 |
ng/ml |
0.7 |
ng/ml |
|
|
| 5335 |
429 |
ZIF@GOx/GQDs |
tumor therapy |
|
|
|
|
|
|
|
enhanced penetration and deep catalytic therapy |
| 5336 |
429 |
ZIF@GOx/GQDs |
tumor therapy |
|
|
|
|
|
|
|
|
| 5338 |
430 |
Pt@MnO2 |
sensitive Salmonella biosensor |
Salmonella |
Color |
15-150000 |
CFU/mL |
13 |
CFU/mL |
|
Then, the detection antibodies (DAbs) modified Pt@MnO2 NFs were used for labelling magnetic bacteria to form MNB-CAb-Salmonella-DAb-Pt@MnO2 NF complexes (nanoflower bacteria). After nanoflower bacteria were resuspended with H2O2 in a sealed centrifuge tube, H2O2 was catalyzed by Pt@MnO2 NFs to produce O2, resulting in the increase on pressure. |
| 5337 |
430 |
Pt@MnO2 |
sensitive Salmonella biosensor |
Salmonella |
Color |
15-150000 |
CFU/mL |
13 |
CFU/mL |
|
|
| 5342 |
433 |
AuNP−TTMA |
protection of biorthogonal transition metal catalysts |
|
|
|
|
|
|
|
We demonstrate here the protection of biorthogonal transition metal catalysts (TMCs) in biological environments by using self-assembled monolayers on gold nanoparticles (AuNPs). |
| 5343 |
433 |
AuNP−TTMA |
protection of biorthogonal transition metal catalysts |
|
|
|
|
|
|
|
|
| 5344 |
435 |
MnNS:CDs |
non-invasive multi-modal imaging and therapy |
|
|
|
|
|
|
|
|
| 5351 |
440 |
PEG-Au/FeMOF@CPT NPs |
Cancer Therapy |
|
|
|
|
|
|
|
Triggered by the high concentration of phosphate inside the cancer cells, Au/FeMOF@CPT NPs effectively collapse after internalization, resulting in the complete drug release and activation of the cascade catalytic reactions. |
| 5352 |
440 |
PEG-Au/FeMOF@CPT NPs |
Cancer Therapy |
|
|
|
|
|
|
|
|
| 5353 |
441 |
Pdots@AMP-Cu |
detection of dopamine |
Dopamine (DA) |
Fluor |
10-400 |
μM |
4 |
μM |
|
|
| 5354 |
443 |
Au-nanozymes and MnO2-nanozymes |
colorimetric method for glutathione (GSH) detection |
GSH |
Color |
0.05-0.19,0.19-11.35 |
mg/L |
0.02 |
mg/L |
|
|
| 5355 |
443 |
Au-nanozymes and MnO2-nanozymes |
colorimetric method for glutathione (GSH) detection |
GSH |
Color |
0.05-0.19,0.19-11.35 |
mg/L |
0.02 |
mg/L |
|
Using Au-nanozymes for selectivity and MnO2-nanozymes for sensitivity enchantment. |
| 5356 |
444 |
HA@Fe3O4@SiO2 |
Colorimetric determination of tumor cells |
tumor cell |
Color |
|
|
|
|
|
|
| 5357 |
444 |
HA@Fe3O4@SiO2 |
Colorimetric determination of tumor cells |
tumor cell |
Color |
|
|
|
|
|
In the presence of HeLa cells, the visible region absorbance sharply decreased up to the cell concentration of 0.25 × 106 cells/mL, with both nanozymes (Fig. 9A). In the concentration range of 0.25–4.0 × 106 cells/mL, the visible region absorbance linearly decreased with the increasing cell concentration, with satisfactorily high correlation coefficients for both nanozymes. However, a sharper linear decrease with almost 1.6 times higher slope was observed with HA@Fe3O4@SiO2 microspheres with respect to Fe3O4@SiO2 microspheres with HeLa cells. |
| 5360 |
446 |
Au@Co-Fe NPs |
antibacterial |
|
|
|
|
|
|
|
|
| 5365 |
450 |
RGD-BSA-CuCs |
catalytic cancer-specific DNA cleavage and operando imaging |
|
|
|
|
|
|
|
|
| 5367 |
451 |
PI/CdS |
detection of hypoxanthine |
hypoxanthine |
E-chem |
0.010-10.0 |
mM |
5.28 |
μM |
95.5 %–105.9 % |
|
| 5366 |
451 |
PI/CdS |
detection of hypoxanthine |
hypoxanthine |
E-chem |
0.010-10.0 |
mM |
5.28 |
μM |
95.5 %–105.9 % |
Human serum samples were diluted 20-fold with phosphate buffer solution (pH 7.4) in advance. |
| 5369 |
452 |
GO/AuNPs |
glucose detection |
glucose |
Color |
5.1×10–6~5.1×10–4 |
M |
6.3×10–7 |
M |
105.3%-108.3% |
|
| 5368 |
452 |
GO/AuNPs |
glucose detection |
glucose |
Color |
5.1×10–6~5.1×10–4 |
M |
6.3×10–7 |
M |
105.3%-108.3% |
The real human serum was used as test samples to investigate the practical application of the proposed analysis. Human serum samples were taken from Xi'a University of Science and Technology Hospital. As the normal content of human blood glucose is 3.9–6.1 mmol/L [38], before the test, the collected serum samples need to be diluted to meet the requirements of this method after centrifugation. The glucose test results are shown in Table 2. For three different test samples, the detection results from this method are not substantially different from those given by the hospital. |
| 5370 |
452 |
GO/AuNPs |
H2O2 detection |
H2O2 |
Color |
3.8×10–7~5.5×10–5 |
M |
4.2×10–8 |
M |
|
|
| 5375 |
456 |
Nanocages |
the laccase-like activity of Nanocages was integrated with an online sensing platform for in vivo and continuous optical hydrogen sulfide monitoring in the brains of living rats |
hydrogen sulfide |
E-chem |
0.1-15 |
μM |
33 |
nM |
|
|
| 5374 |
456 |
Nanocages |
the laccase-like activity of Nanocages was integrated with an online sensing platform for in vivo and continuous optical hydrogen sulfide monitoring in the brains of living rats |
hydrogen sulfide |
E-chem |
0.1-15 |
μM |
33 |
nM |
|
After testing the excellent capabilities of the OODP toward H2S monitoring, the animal model was carried out to test the ability of the constructed method. |
| 5376 |
456 |
Nanocages |
The peroxidase- and catalase-mimicking activities were applied to eliminate reactive oxygen species in cells |
|
|
|
|
|
|
|
|
| 5377 |
457 |
CuS-BSA-Cu3(PO4)2 |
detection of H2O2 |
H2O2 |
Color |
0–8 |
μM |
22 |
nM |
98.12-101.9% |
Typically, using a standard addition method, H2O2 at 20, 50, and 100 nM is spiked into contact lens care solution obtained from a pharmacy. The H2O2 content present in lens care solution is determined from an already established calibration plot, generated at 654 nm using different H2O2 concentrations under the same assay mentioned above. Percentage recovery is assessed using Eq. (8), and the results are summarized in Table 3 (n = 3). |
| 5378 |
457 |
CuS-BSA-Cu3(PO4)2 |
detection of H2O2 |
H2O2 |
Color |
0–8 |
μM |
22 |
nM |
98.12-101.9% |
|
| 5379 |
458 |
Fe3O4@MnOx |
quantifying and identifying chlorophenols |
chlorophenols |
Color |
10–1600 |
μM |
0.85 |
μM |
97.0% to 107.2% |
|
| 5380 |
458 |
Fe3O4@MnOx |
quantifying and identifying chlorophenols |
chlorophenols |
Color |
10–1600 |
μM |
0.85 |
μM |
97.0% to 107.2% |
In the present study, the tap water was obtained from our research laboratory, and the river water was gained from the campus of Jiangsu University, China. Prior to test, these water samples were filtered by 0.22 μm microfiltration membranes. The detection results are listed in Table S2 (Supplementary Information). |
| 5383 |
459 |
Ag-MA |
selective colorimetric and efficient removal strategy for mercury (II) |
Hg2+ ions |
Color |
0.50-700 |
nM |
0.18 |
nM |
98.15–105.1 % |
Hg2+ ions in wastewater samples |
| 5381 |
459 |
Ag-MA |
selective colorimetric and efficient removal strategy for mercury (II) |
Hg2+ ions |
Color |
1.0-600 |
nM |
0.33 |
nM |
|
|
| 5382 |
459 |
Ag-MA |
selective colorimetric and efficient removal strategy for mercury (II) |
Hg2+ ions |
Color |
0.10–700 |
nM |
0.025 |
nM |
|
Fig. 6A illustrates the calibration detection curve for Hg2+ ions in buffer |
| 5384 |
459 |
Ag-MA |
selective colorimetric and efficient removal strategy for mercury (II) |
Hg2+ ions |
Color |
1.0-600 |
nM |
0.33 |
nM |
|
probe Hg2+ ions in blood |
| 5389 |
463 |
ZV-Mn NPs |
Detection of hydrogen peroxide |
H2O2 |
Color |
10–280 |
μM |
0.20 |
μM |
|
|
| 5392 |
465 |
Pt NC/3D GF nanohybrid |
Detection of Catechol and Hydroquinone |
HQ |
Color |
0.05–1 and 1–50 |
μM |
10 |
nM |
95.8-99.6% |
|
| 5393 |
465 |
Pt NC/3D GF nanohybrid |
Detection of Catechol and Hydroquinone |
Catechol |
Color |
0.5-800 |
μM |
50 |
nM |
|
|
| 5394 |
465 |
Pt NC/3D GF nanohybrid |
Detection of Catechol and Hydroquinone |
HQ |
Color |
0.05–1 and 1–50 |
μM |
10 |
nM |
95.8-99.6% |
different concentrations of HQ were spiked in the systems containing CC and then analyzed with the means |
| 5391 |
465 |
Pt NC/3D GF nanohybrid |
Detection of Catechol and Hydroquinone |
Catechol |
Color |
0.5-800 |
μM |
50 |
nM |
|
As shown in Figure 6, after incubation with the Pt NC/3D GF nanohybrid in pH 7.0 BR buffer at 30 °C for 15 min, the absorbance of the system at 388 nm gradually increased with the increase of catechol concentration. |
| 5422 |
477 |
NC@GOx NPs |
Starvation therapy enhanced photothermal and chemodynamic tumor therapy |
|
|
|
|
|
|
|
|
| 5423 |
478 |
DNA/MoS2 NSs |
Detection of carcinoembryonic antigen (CEA) in a sensitive manner |
carcinoembryonic antigen (CEA) |
Color |
50-1000 |
ng/mL |
50 |
ng/mL |
|
|
| 5424 |
479 |
GO/PVA/G4/H hydrogel |
Electrochemical detection of H2O2 |
H2O2 |
E-chem |
100-100000000 |
nM |
100 |
nM |
|
|
| 5425 |
483 |
DMSN@AuPtCo |
Decontaminate two kinds of wastewater and avoiding secondary pollution |
|
|
|
|
|
|
|
|
| 5427 |
484 |
Co3O4/MO3 |
Sense H2O2 and screen acetylcholinesterase activity and its inhibitor |
acetylcholinesterase (AChE) |
Color |
0.005-1.0 |
U/L |
0.1 |
mU/L |
|
|
| 5426 |
484 |
Co3O4/MO3 |
Sense H2O2 and screen acetylcholinesterase activity and its inhibitor |
H2O2 |
Color |
0.1-200 |
μM |
0.08 |
μM |
|
|
| 5431 |
488 |
HRP/MB/chitosan/MoS2/GF |
Enhanced voltammetric determination of hydrogen peroxide |
H2O2 |
E-chem |
0.1-90 |
μM |
30 |
nM |
|
|
| 5432 |
489 |
Fe/Al-GNE |
pH-independent chemodynamic therapy of cancer |
|
|
|
|
|
|
|
|
| 5436 |
492 |
CoPc |
Determination of hydrogen peroxide and glucose |
H2O2 |
E-chem |
12.3–49 000 |
μM |
8 |
μM |
|
|
| 5435 |
492 |
CoPc |
Determination of hydrogen peroxide and glucose |
glucose |
E-chem |
0.1-1 |
mM |
63 |
μM |
|
|
| 5439 |
495 |
β-CD@AuNPs–MWCNTs |
Sensitive electrochemical analysis of target 8-hydroxy-2′-deoxyguanosine (8-OHdG) based on reversible capture/release of electronic media in a fast and green manner |
8-hydroxy-2′-deoxyguanosine |
E-chem |
0.0001-10 |
nM |
30 |
fM |
|
|
| 5440 |
496 |
CS-MNPs |
Colorimetric Bacteria Detection |
bacteria |
Color |
10^2-10^6 |
CFU/mL |
10^2 |
CFU/mL |
|
|
| 5442 |
498 |
SPDA |
Colorimetric detection of pyrophosphate |
pyrophosphate |
Color |
0.1-30 |
μM |
0.06 |
μM |
|
|
| 5444 |
500 |
CNF/FeCDs |
Smartphone-based colorimetric detection of hydrogen peroxide and glucose |
glucose |
Color |
10-70 |
μM |
1.73 |
μM |
|
|
| 5443 |
500 |
CNF/FeCDs |
Smartphone-based colorimetric detection of hydrogen peroxide and glucose |
H2O2 |
Color |
6-42 |
μM |
0.93 |
μM |
|
|
| 5445 |
501 |
Cu-HCF SSNEs |
Tumor-Specific Amplified Cascade Enzymatic Therapy |
|
|
|
|
|
|
|
|
| 5446 |
502 |
M/CeO2 |
Detection of H2O2 and glucose |
H2O2 |
Color |
10-100 |
μM |
2 |
μM |
|
|
| 5447 |
502 |
M/CeO2 |
Detection of H2O2 and glucose |
glucose |
Color |
0.01-1 |
mM |
8.6 |
μM |
|
|
| 5455 |
511 |
ZnO-Pt-gC3N4 |
glucose sensing |
glucose |
E-chem |
0.25–110 |
mM |
0.1 |
μM |
100, 98.2 and 95% |
|
| 5456 |
512 |
NiCo2O4-Au composite |
for killing bacteria and disinfecting wound |
|
|
|
|
|
|
|
|
| 5459 |
517 |
GOx@h-CNT/Fe3O4/ZrO2 |
Colorimetric detection of glucose |
glucose |
Color |
0–1.6 |
mM |
6.9 |
μM |
|
|
| 5461 |
520 |
MPBN |
Analysis of RAC and CLE in real samples |
CLE |
Color |
0.5-12 |
ng/mL |
0.20 |
ng/mL |
86.96%–119.94% |
|
| 5462 |
520 |
MPBN |
Analysis of RAC and CLE in real samples |
RAC |
Color |
0.5-6 |
ng/mL |
0.12 |
ng/mL |
84.01% - 119.94% |
|
| 5464 |
522 |
MIL-88@Pt@MIL-88@sDNA |
exosomal miRNAs detection |
exosomal miRNAs |
E-chem |
1 fM to 1 nM |
|
2.00 |
fM |
|
|
| 5467 |
524 |
Pd@Pt-GOx/hyaluronic acid (HA |
for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy |
|
|
|
|
|
|
|
|
| 5468 |
525 |
Gold and magnetic particles (GoldMag) |
for determination of cholesterol |
cholesterol |
Color |
0.018–1.4 |
mM |
7.9 |
μM |
98.57%-106.8% |
|
| 5469 |
526 |
Pt2+@g-C3N4 |
for glucose detection |
glucose |
Color |
13–2000 |
μM |
10 |
μM |
|
|
| 5473 |
529 |
man-PB |
for rapid detection of Escherichia coli O157:H7 (E. coli O157:H7) |
Escherichia coli O157:H7 (E. coli O157:H7) |
Color |
0-108 |
cfu/mL |
102 |
cfu/mL |
90% - 110% |
|
| 5474 |
530 |
HCS@Pt NPs |
for photodynamic and catalytic synergistic tumor therapy |
|
|
|
|
|
|
|
|
| 5477 |
533 |
Ag-CoO NP |
for colorimetric sensing hydrogen peroxide and o-phenylenediamine |
o-phenylenediamine |
Color |
1−20 |
μM |
0.65 |
μM |
|
|
| 5476 |
533 |
Ag-CoO NP |
for colorimetric sensing hydrogen peroxide and o-phenylenediamine |
hydrogen peroxide |
Color |
5-20 |
μM |
3.47 |
μM |
|
|
| 5478 |
534 |
Ag@Ag2WO4 NRs |
for colorimetric detection of Hg2+ |
Hg2+ |
Color |
0.25 - 8.0 |
μM |
1.6 |
nM |
95.0% -106.0% |
|
| 5482 |
537 |
MoS2/C-Au600 |
MoS2/C-Au600 with peroxidase-like activity can image cancer cells in the presence of TMB and H2O2 |
|
|
|
|
|
|
|
|
| 5481 |
537 |
MoS2/C-Au600 |
Detection of H2O2 |
H2O2 |
Color |
10-200 |
µmol/L |
1.82 |
µmol/L |
|
|
| 5485 |
540 |
Fe3O4@CP |
Detection of GSH |
GSH |
Color |
0.2-40 |
μM |
0.05 |
μM |
|
|
| 5486 |
540 |
Fe3O4@CP |
Detection of H2O2 |
H2O2 |
Color |
0.2-300 |
μM |
0.11 |
μM |
|
|
| 5495 |
555 |
MnO2–Au |
antitumor |
|
|
|
|
|
|
|
|
| 5498 |
558 |
Fe3O4@NH2-MIL-101(Fe) |
colorimetric detection of glucose |
glucose |
Color |
1.7-750 |
μM |
0.22 |
μM |
100.5 |
|
| 5499 |
559 |
Ni/Al–Fe(CN)6 LDH |
Determination of Cr (VI) |
Cr (VI) |
Fluor |
0.067-10 |
μM |
0.039 |
μM |
|
|
| 5502 |
563 |
ficin@PCN-333(Fe) |
colorimetric detection of glucose |
glucose |
Color |
0.5-180 |
μM |
96 |
nM |
|
|
| 5504 |
566 |
Cerium Oxide NSs |
Detection of H2O2 |
H2O2 |
Electrode |
20–100 |
mM |
0.02 |
μM |
|
|
| 5508 |
570 |
DNA-Cu/Ag NCs |
Detection of H2O2 |
H2O2 |
colorimetric |
100-1000 |
μM |
7.42 |
μM |
|
|
| 5510 |
572 |
CFPN |
oxidation of natural organic matters |
|
|
|
|
|
|
|
|
| 5511 |
573 |
AgNPs@Fe3O4 |
Detection of cysteine |
cysteine |
colorimetric |
0-20 |
μM |
87 |
nM |
|
|
| 5512 |
574 |
Pt-HMCNs |
Detection of H2O2 |
H2O2 |
colorimetric |
6.0-60 |
μM |
2.81 |
μM |
|
|
| 5515 |
576 |
EMSN-PtNCs |
Detection of H2O2 |
H2O2 |
colorimetric |
1-50 |
μM |
0.87 |
μM |
|
|
| 5521 |
582 |
Ag5PMo12@PPy |
detection of uric acid |
uric acid |
colorimetric |
1-50 |
μM |
0.47 |
μM |
|
|
| 5524 |
585 |
Fe3O4-PAA-PB-AA |
Fenton/ferroptosis therap |
ROS |
|
|
|
|
|
|
|
| 5525 |
587 |
CeO2 microcapsule |
assessing |
intracellular ROS |
|
|
|
|
|
|
|
| 5526 |
588 |
PPy@MoS2@Au |
detection of tannic acid |
tannic acid |
colorimetric |
1.0-100 |
μM |
0.87 |
μM |
|
|
| 5528 |
591 |
TACN AuNPs |
anticancer prodrugs |
|
|
|
|
|
|
|
|
| 5529 |
592 |
Au−Cu2−xS |
photothermal therapy and chemical dynamic therapy |
|
|
|
|
|
|
|
|
| 5530 |
594 |
Pt/ZnCo2O4 |
Detection of ascorbic acid |
Ascorbic acid (AA) |
|
1-15 |
μM |
0.456 |
μM |
|
|
| 5531 |
596 |
GOx@Pd@ZIF-8 |
a synergistic cancer therapeutic that blocks glucose metabolism and produces ROS |
|
|
|
|
|
|
|
|
| 5532 |
597 |
6-PAAC-30 |
alcohol and glucose detection |
glucose |
E-chem |
0-40 |
mM |
2.50 |
mM |
|
|
| 5533 |
597 |
6-PAAC-30 |
alcohol and glucose detection |
alcohol |
E-chem |
0-6 |
mM |
0.50 |
mM |
|
|
| 5535 |
599 |
Pd91-GBLP NPs |
the colorimetric detection of glucose |
glucose |
Color |
2.5-700 |
μM |
1 |
μM |
|
|
| 5536 |
600 |
PtNPs@PCs |
lead ion detection |
lead ion |
E-chem |
0.05-1000 |
nM |
0.018 |
nM |
|
|
| 5537 |
601 |
AuMS |
the selective colorimetric detection of dopamine |
Dopamine (DA) |
Color |
10-80 |
μM |
1.28 |
nM |
|
|
| 5539 |
603 |
ACP/hemin@Zn-MOF |
ratiometric fluorescent arsenate sensing |
arsenate |
Fluor |
3.33-300 |
μg/L |
1.05 |
μg/L |
|
|
| 5540 |
604 |
GO/AuNPs |
detection of Hg2+ |
Hg2+ |
Color |
5.2-120 |
nM |
0.38 |
nM |
|
|
| 5543 |
606 |
Pt NPs-PVP |
theranostic application in acute kidney injury |
|
|
|
|
|
|
|
|
| 5544 |
607 |
Cu-rGO |
Colorimetric detection of H2O2 and glucose |
glucose |
Color |
10-100 |
μM |
10 |
μM |
|
|
| 5545 |
607 |
Cu-rGO |
Colorimetric detection of H2O2 and glucose |
H2O2 |
Color |
10-100 |
μM |
0.1 |
μM |
|
|
| 5546 |
609 |
Mn3(PO4)2/MXene |
realtime sensitive sensing cell superoxide |
O2•− |
E-chem |
5.75-25930 |
nM |
1.63 |
nM |
|
|
| 5547 |
610 |
FePc/HNCSs |
ynergistic Catalytic Therapy and Dual Phototherapy |
|
|
|
|
|
|
|
|
| 5551 |
614 |
PbS NPs@RGO/NiO NSAs |
Function-switchable self-powered photoelectrochemical biosensor for H2O2 and glucose monitoring |
H2O2 |
|
0-100 |
mM |
0.018 |
mM |
|
|
| 5552 |
614 |
PbS NPs@RGO/NiO NSAs |
Function-switchable self-powered photoelectrochemical biosensor for H2O2 and glucose monitoring |
glucose |
|
0.1 ~ 1 × 10-7 |
M |
5.3*10-8 |
M |
|
|
| 5553 |
615 |
Pt-Ce6 |
enhanced PDT/PTT tumor therapy |
|
|
|
|
|
|
|
|
| 5554 |
617 |
LM |
portable immunoassay of allergenic proteins based on A smartphone |
α-LA |
|
0.12-3.46 |
ng/mL |
0.056 |
ng/mL |
|
|
| 5556 |
619 |
DFHHP |
overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors |
|
|
|
|
|
|
|
|
| 5558 |
622 |
TiO2/Bi2WO6/Ag heterojunction |
hydrogen sulfide detection |
H2S |
|
0.5-100 |
μM |
0.06 |
μM |
|
|
| 5559 |
622 |
TiO2/Bi2WO6/Ag heterojunction |
hydrogen sulfide detection |
H2S |
E-chem |
0.5-300 |
μM |
0.08 |
μM |
|
|
| 5560 |
623 |
thiamine-MnO2 |
A thiamine-triggered fluormetric assay for acetylcholinesterase activity and inhibitor screening |
acetylcholinesterase (AChE) |
Fluor |
0.02-1 |
mU/mL |
15 |
μU/mL |
|
|
| 5561 |
624 |
AMP-Cu |
Efficient elimination and detection of phenolic compounds in juice |
phenolic compounds |
|
0.1-100 |
μmol·L−1 |
0.033 |
μmol·L−1 |
|
|
| 5563 |
626 |
AuPd @MnO2 |
Detection of Tetrabromobisphenol A |
Tetrabromobisphenol A |
E-chem |
0.44-46.49 |
ng/mL |
0.10 |
ng/mL |
|
|
| 5567 |
630 |
POMOFs@PDDA-rGO |
Detection of H2O2 and Citric acid |
Citric acid |
|
1–60 |
μM |
2.07 |
μM |
|
|
| 5569 |
636 |
MWCNT@MoS2 NS's |
Determination of 5-Nitroguaiacol |
|
|
0.1–70 |
μM |
0.02 |
μM |
|
|
| 5577 |
648 |
Au/OMCS |
Electrochemical Sensor |
Xanthine |
E-chem |
0.10–20 |
μM |
0.006 |
μM |
|
|
| 5583 |
655 |
Cu-Carbon dots |
Detection |
Cr |
Fluor |
0.2-100 |
μM |
36 |
nM |
|
|
| 5588 |
659 |
Mn/Ni(OH)x LDHs |
antibacteria |
|
|
|
|
|
|
|
|
| 5589 |
660 |
Fe3O4/Au NPs |
detection of Staphylococcus aureus |
S. aureus |
Color |
10 ~ 1000000 |
cfu/mL |
10 |
cfu/mL |
|
|
| 5590 |
661 |
Fe-SAzyme |
detection of galactose |
TMB |
Color |
50-500 |
μM |
10 |
μM |
104.83~105.33% |
|
| 5593 |
664 |
NLISA-T |
detection of serum |
TMB |
Color |
0.1-10 |
ng/mL |
0.08 |
ng/mL |
|
|
| 5594 |
664 |
NLISA-H |
detection of serum |
HAuCl4 |
Color |
0.1-10 |
ng/mL |
0.05 |
|
|
|
| 5603 |
673 |
metallo-nanozymes |
This work highlights the minimal principle and excellent catalytic performance of stable metallo-nanozymes, opening up immense opportunities in the development of highly efficient nanozymes and catalytic prodrug conversion. |
|
|
|
|
|
|
|
|
| 5609 |
679 |
R-MnCo2O4 |
construct highly sensitive biosensors. |
TMB |
Color |
|
|
|
|
|
|
| 5611 |
682 |
Cu-Cys NLs |
detetion of epinephrine |
epinephrine |
Color |
9–455 |
μM/L |
2.7 |
μM/L |
100.1-108.3% |
|
| 5612 |
683 |
BiVO4 |
detection of β-lactoglobulin |
β-lactoglobulin |
E-chem |
0.01-1000 |
ng/mL |
0.007 |
ng/mL |
|
|
| 5616 |
689 |
Fe@NCDs |
detection of uric acid |
uric acid |
Color |
2–150 |
μM |
0.64 |
μM |
|
|
| 5618 |
691 |
Fe-doped g-C3N4 nanoflake |
detection of hydrogen peroxide (H2O2) |
H2O2 |
Color |
2-100 |
μM |
1.8 |
μM |
|
|
| 5619 |
691 |
Fe-doped g-C3N4 nanoflake |
detection of sarcosine (SA) |
SA |
Color |
10-500 |
μM |
8.6 |
μM |
|
|
| 5621 |
693 |
Au-Fe2O3 |
cancer assay detection |
T47D cancer cell line |
E-chem |
10–100000 |
cells ml−1 |
0.4 |
U ml−1 |
|
|
| 5622 |
694 |
graphene/Fe3O4-AuNP |
detection of Pb2+ |
Pb2+ |
Color |
1–300 |
ng/mL |
0.63 |
ng/mL |
|
|
| 5624 |
696 |
Fe3O4@MnO2 |
enhance the radiosensitivity |
|
|
|
|
|
|
|
|
| 5625 |
699 |
MCDs-MnO2 NPs |
detection of food- and water-borne pathogens |
gram-negative bacterium and the gram-positive bacterium |
Color |
10 to 1000000 |
cfu mL−1 |
100 |
cfu mL−1 |
|
|
| 5627 |
701 |
Hep-Pd NPs |
determination of Pro |
protamine |
Color |
0.02 ~ 0.8 |
μg mL−1 |
0.014 |
μg mL−1 |
|
|
| 5628 |
702 |
CSA-based nanoparticles |
detection of H2O2 |
H2O2 |
Color |
5-400 |
μM |
3.32 |
μM |
|
|
| 5629 |
703 |
GO/Ag |
biosensing |
|
|
|
|
|
|
|
|
| 5630 |
704 |
Au-hematene |
glucose sensor |
glucose |
E-chem |
0-3.2 mM |
mM |
0.4 |
mM |
|
|
| 5631 |
705 |
ATF |
detection of cancer cells |
cancer cells |
|
|
|
2000 |
cancer cells/mL |
|
|
| 5633 |
708 |
Mn-MPSA-PCC |
monitoring of O2 •− released from cancer cells |
O2 •− |
E-chem |
|
|
|
|
|
|
| 5634 |
709 |
HA-PB/ICG |
drug delivery |
|
|
|
|
|
|
|
|
| 5635 |
710 |
LaMNPs |
inhibition of the tumor growth |
|
|
|
|
|
|
|
|
| 5636 |
711 |
DhHP-6-c-ZrMOF |
promising catalyst for the high-efficiency degradation of phenol pollutants |
|
|
|
|
|
|
|
|
| 5637 |
712 |
hemin-GroEL |
detection of glucose |
glucose |
Fluor |
0-6 |
mM |
|
|
|
|
| 5638 |
713 |
SOD-Fe0@Lapa-ZRF |
kill tumor cells via the multi-enzyme cascades |
|
|
|
|
|
|
|
|
| 5639 |
714 |
A-nanoceria |
an effective alternative to the current DMARDs in RA therapy |
|
|
|
|
|
|
|
|
| 5641 |
717 |
Fe2O3/CNTs |
Highly Efficient Dopamine Sensing |
Dopamine (DA) |
Color |
0-25 |
μM |
0.11 |
μM |
|
|
| 5644 |
722 |
PtNPs@MWCNTs |
NADH detection |
NADH |
|
1-200 |
μM |
0.8 |
μM |
|
|
| 5645 |
722 |
PtNPs@MWCNTs |
xylose biosensor |
xylose |
E-chem |
5-400 |
μM |
1 |
μM |
|
|
| 5646 |
723 |
dex-MoSe2 NS |
detection of glucose |
glucose |
Color |
0.04-0.40 |
mM |
0.028 |
mM |
97.2%-106.1% |
|
| 5647 |
725 |
laccase/Fe-BTC-NiFe2O4 |
degrade pollutants in water |
|
|
|
|
|
|
|
|
| 5651 |
728 |
GOx@MOF |
One-step cascade detection of glucose at neutral pH |
glucose |
Color |
8-140 |
μM |
2.67 |
μM |
|
|
| 5652 |
729 |
Ags-APMSNs |
Mumps Virus Diagnosis |
mumps-specific IgM antibodies |
Color |
10-100000 |
ng/mL |
10 |
ng/mL |
|
|
| 5661 |
738 |
LIPIA |
as Chiral Scaffolds for Supramolecular Nanozymes |
|
|
|
|
|
|
|
|
| 5662 |
739 |
QG |
Slowed Inflammation and Increased Tissue Regeneration in Wound Hypoxia |
|
|
|
|
|
|
|
|
| 5663 |
740 |
SP-SPIO-IR780 and SPA-SPIO-IR780 |
Dual-modality Imaging Guided Nanoenzyme Catalysis Therapy and Phototherapy |
|
|
|
|
|
|
|
|
| 5666 |
743 |
ADH/GOx@TM |
sustainable catalytic NAD+ /NADH cycling |
|
|
|
|
|
|
|
|
| 5668 |
745 |
Pt/WO2.72 |
H2O2 detection |
H2O2 |
Color |
0.005-12 |
mM |
2.33 |
μM |
|
|
| 5669 |
745 |
Pt/WO2.72 |
glucose detection |
glucose |
Color |
0.01-0.6 |
mM |
5.9 |
μM |
|
|
| 5670 |
745 |
Pt/WO2.72 |
radical elimination |
|
|
|
|
|
|
|
|
| 5671 |
747 |
2D Co3O4@Rh NC |
colorimetric sensing of urea and p-Ap |
UREA |
Color |
6-165 |
μM |
1.1 |
μM |
96-105.8 |
|
| 5672 |
747 |
2D Co3O4@Rh NC |
colorimetric sensing of urea and p-Ap |
p-aminophenol |
Color |
1.7-105 |
μM |
0.68 |
μM |
96-105.8 |
|
| 5676 |
750 |
Ag2S@GO |
Hg2+ |
|
|
|
|
9.8 × 10^–9 |
M |
97.0–101.8% a |
|
| 5677 |
751 |
BP/Pt-Ce6@PEG NSs |
a Pt nanoenzyme functionalized nanoplatform BP/PtCe6@PEG NSs has been fabricated for fluorescence imaging-guided synergistic photothermal and enhanced photodynamic therapy. |
|
|
|
|
|
|
|
|
| 5679 |
753 |
Au/Cu2O |
In this work, we assessed the antioxidant behavior of three natural antioxidants (TA1, GA, TA2) on TMB oxidation catalyzed by Au/Cu2O heterostructures in the presence of H2O2 via colorimetric method |
tannic acid |
Color |
0-16 |
μM |
0.039 |
μM |
|
|
| 5680 |
753 |
Au/Cu2O |
In this work, we assessed the antioxidant behavior of three natural antioxidants (TA1, GA, TA2) on TMB oxidation catalyzed by Au/Cu2O heterostructures in the presence of H2O2 via colorimetric method |
gallic acid |
Color |
0-75 |
μM |
0.16 |
μM |
|
|
| 5681 |
753 |
Au/Cu2O |
In this work, we assessed the antioxidant behavior of three natural antioxidants (TA1, GA, TA2) on TMB oxidation catalyzed by Au/Cu2O heterostructures in the presence of H2O2 via colorimetric method |
tartaric acid |
Color |
0-100 |
μM |
1.55 |
μM |
|
|
| 5682 |
753 |
Au/Cu2O |
Therefore, it is vital important to explore a fast, sensitive method to accurate determination of H2O2 in the biological environment. On the basis of high peroxidase activity of Au/Cu2O nanocatalyst, a simple and flexible colorimetric sensor was constructed to detect H2O2 in this work. |
H2O2 |
Color |
0.1-200 |
μM |
0.054 |
μM |
|
|
| 5684 |
755 |
COF-AI-ECL |
The selectivity of the sensor for CAP in the presence of matrix interferences was analysed. Common veterinary antibiotics, such as tetracycline, aureomycin, oxytetracycline, doxycycline, thiamphenicol, virginiamycin, lincomycin, penicillin, amoxicillin, and florfenicol, as well as common metal ions, such as Fe2+, Fe3+, Cd2+, Al3+, Cr3+, Cu2+, Zn2+, Hg2+, Co2+, and Ca2+, were used to prepare a complex matrix sample containing CAP (5 ×10−11 mol/L), 10 antibiotics (5 × 10−8 mol/ L each), and 10 metal ions (5 × 10−7 mol/L each). The ECL responses (ΔI) to the 5 × 10−11 mol/L CAP standard sample and the complex matrix sample were similar (relative deviation < 5.0%) (Fig. S11). Using the same method, the influence of each individual interference on the ECL response was investigated. The results showed that common veterinary antibiotics and common metal ions affect the intensity of the detected signal by less than 5.0% |
chloramphenicol |
E-chem |
5*10-13-4*10-10 |
M |
1.18*10-13 |
M |
85%-106.2% |
|
| 5685 |
756 |
MNP-bacteria-MnO2@GOx complexes |
detection of Salmonella typhimurium |
Salmonella typhimurium |
E-chem |
10-106 |
CFU/ml |
10 |
CFU/ml |
|
|
| 5686 |
757 |
BSA-Cu complex |
Catalytic degradation of malachite green |
malachite green |
Color |
|
|
|
|
|
|
| 5688 |
759 |
AuNP–CeO2 NP@GO |
detection of nitrite |
Nitrite |
Color |
100-5000 |
μM |
4.6 |
μM |
|
|
| 5689 |
760 |
2Arg@FeOOH |
detect and remove inorganic arsenic from polluted water |
Arsenic |
Color |
0.67-3333.33 |
μg/ml |
0.42 |
μg/ml |
95-105 |
|
| 5691 |
762 |
Co-MOF/CC/Paper |
detection of glucose |
glucose |
E-chem |
0.8-16 |
mM |
0.15 |
mM |
|
|
| 5692 |
763 |
Co3O4-Au polyhedron |
miRNA detection |
|
|
|
|
|
|
93.0–113.0% |
|
| 5693 |
766 |
nanoceria-PTA*-AuNPs |
conversion of 4-NP into 4-AP |
|
|
|
|
|
|
|
|
| 5694 |
768 |
Co3O4 HNCs |
colorimetric biosensing of dopamine |
DA |
Color |
0.02-3.5 / 4.75–90 |
μM |
0.015 |
μM |
98.4%–101.6% |
As shown in Table S2, for the three groups of samples, the recovery rate is 96.0%–106.5% with low DA concentration, and 98.4%–101.6% with high DA concentration. |
| 5695 |
769 |
UiO-66-Fc |
detect H2O2 |
H2O2 |
Color |
50 to 500 |
μM |
0.23 |
μM |
|
|
| 5696 |
769 |
UiO-66-Fc |
detect glucose |
glucose |
Color |
5-600 |
μM |
2.32 |
μM |
|
|
| 5697 |
769 |
UiO-66-Fc |
detect Uric acid |
Uric acid |
Color |
50-600 |
μM |
1.18 |
μM |
|
|
| 5699 |
773 |
CS-Cu-GA NCs |
antibacterial |
|
|
|
|
|
|
|
|
| 5701 |
775 |
MPBzyme@NCM |
Ischemic Stroke Therapy |
|
|
|
|
|
|
|
|
| 5706 |
780 |
CuS-BSA-Cu3(PO4)2 |
Colorimetric sensing of dopamine in beef meat |
Dopamine (DA) |
Color |
0.05–100 |
µM |
0.13 |
µM |
|
|
| 5707 |
781 |
mAb-PtDEN-GOD |
assisted immunoassay for C-reactive protein |
C-reactive protein (CRP) |
Unsure |
0.01-100 |
ng/mL |
5.9 |
pg/mL |
|
As seen from Fig. 3c, pH variations could maintain ≥ 95% of the initial signal within 8 months. After storing for 11 months, the signal could also preserve more than 90%. |
| 5708 |
782 |
MnO2 |
detector for on-site monitoring of organophosphorus pesticide |
Organophosphorus pesticides |
Color |
0.0005-1.5 |
μg/mL |
0.5 |
ng/mL |
|
|
| 5709 |
783 |
CeO2/CePO4 |
antibacterial efficacy |
|
|
|
|
|
|
|
|
| 5710 |
784 |
AuPt@SF (APS) |
Antitumor |
|
|
|
|
|
|
|
|
| 5711 |
785 |
GOD@ Cu-hemin MOFs |
colorimetric analysis of glucose |
glucose |
Color |
0.01–1.0 |
mM |
2.8 |
μM |
|
|
| 5714 |
789 |
NiMn LDH |
used for the highly sensitive detection of H2O2 and ascorbic acid (AA). |
H2O2 |
Color |
0.00125-0.03 |
mM |
0.04 |
μM |
|
|
| 5715 |
789 |
NiMn LDH |
used for the highly sensitive detection of H2O2 and ascorbic acid (AA). |
Ascorbic acid (AA) |
Color |
0-20 |
μM |
0.014 |
μM |
|
|
| 5718 |
792 |
Dex-IONP-GOx |
a bi-functional hybrid nanozyme against a biofilm-related disease in a controlled-manner activated by pathological conditions. |
|
|
|
|
|
|
|
|
| 5719 |
793 |
g-C3N4/hemin/Au |
cell apoptosis monitoring |
|
|
|
|
|
|
|
|
| 5722 |
796 |
CuS-BSA-Cu3(PO4)2 |
Colorimetric assay for sensing dopamine (DA) |
Dopamine (DA) |
Color |
0.05-100 |
μM |
0.13 |
μM |
|
|
| 5723 |
797 |
Au25(p-MBSA)18 |
This pH-dependent peroxidase-mimicking activity is expected to have broad application prospects for Au25(p-MBSA)18 in the biomedical field. For example, in tumor cells with acidic pH,(33) Au25(p-MBSA)18 is expected to be stable, and it can increase the production of intracellular •OH to induce tumor death. |
|
|
|
|
|
|
|
|
| 5725 |
799 |
Ce/ZnCo2O4 |
Detection of H2O2 |
H2O2 |
Color |
200-1000 |
μM |
175 |
μM |
|
|
| 5726 |
799 |
Ce/ZnCo2O4 |
Detection of GSH |
GSH |
Color |
2-15 |
μM |
1.39 |
μM |
101.0 − 103.5 |
|
| 5728 |
801 |
CSPQ@CM |
Therapy of Parkinson’s Disease |
|
|
|
|
|
|
|
|
| 5731 |
806 |
CD44MMSN/AuNPs |
enhanced precise hepatocellular carcinoma therapy |
|
|
|
|
|
|
|
|
| 5739 |
814 |
AuNPs/Cu-TCPP(Fe) |
Detection of Glucose |
glucose |
SERS |
0.16-8 |
mM |
3.9 |
μM |
96.9-100.8% |
|
| 5740 |
815 |
PANI@MoS2@Fe3O4/Pd |
Detection of hydrogen peroxide (H2O2) |
H2O2 |
Color |
2.5-350 |
μM |
1 |
μM |
|
|
| 5741 |
816 |
Fe3O4@Cu/GMP–GOx |
Detection of Glucose |
glucose |
Color |
0-800 |
μM |
5.516 |
μM |
97.6-102.9% |
|
| 5742 |
816 |
Fe3O4@Cu/GMP–GOx |
Detection of Arbutin |
Arbutin |
Color |
0-60 and 100-400 |
μM |
0.766 |
μM |
99.3-104.5% |
|
| 5753 |
828 |
Pt/CoFe2O4 |
Detection of H2O2 and DA |
H2O2 |
Color |
0.1-0.9 |
mM |
0.076 |
mM |
|
|
| 5754 |
828 |
Pt/CoFe2O4 |
Detection of H2O2 and DA |
Dopamine (DA) |
Color |
20–80 |
μM |
0.42 |
μM |
95.5%-101.5% |
|
| 5755 |
829 |
NiMn2O4/C NLM |
Detection of AA |
AA |
Color |
0–13.3 |
μM |
0.047 |
μM |
100.25%-100.39% |
|
| 5757 |
831 |
PdFe/GDY |
Detection of GSH |
GSH |
Color |
50-10000 |
nM |
24.45 |
nM |
86.0%-122.0% |
Based on the peroxidase-like activity of PdFe/GDY as well as the inspiration from the concept of enzymatic induced ROS mediating bacterial cell membrane destruction |
| 5758 |
833 |
Pt/CdS |
detection of H2O2 |
H2O2 |
Color |
0.10–1.00 |
mM |
45.5 |
μM |
|
|
| 5759 |
833 |
Pt/CdS |
detect hydroquinone (HQ) |
HQ |
Color |
1.0–10 |
μM |
0.165 |
μM |
83.56-91.76% |
|
| 5760 |
834 |
CPP Nanoflare |
detection of H2O2 |
H2O2 |
Color |
5 × 10−6 - 5000 × 10−6 |
M |
1.2 × 10−6 |
M |
|
|
| 5761 |
834 |
CPP Nanoflare |
detection of H2O2 |
H2O2 |
Fluor |
50 × 10−9 - 5 × 10−3 |
M |
|
|
|
CPP Nanozyme-Mediated Pathogens Elimination and Biofilm Eradication |
| 5762 |
835 |
AuVCs |
Detection of GSH |
GSH |
Color |
25–500 |
μM |
9.8 |
μM |
99.64–104.71% |
The easy-to-use LFPB with smartphone could achieve a limit of detection of 9.8 μM and a wide range of 25–500 μM for GSH. |
| 5765 |
837 |
FeSe2/Dox@Chi@Gel NCs |
controlled drug delivery and synergistic tumor suppression |
|
|
|
|
|
|
|
|
| 5767 |
839 |
Fe@ZIF-8@GOx NRs |
kill cancer cells |
|
|
|
|
|
|
|
|
| 5769 |
841 |
Fe3O4/MGO |
glucose detection |
glucose |
E-chem |
0.1-16 |
mM |
|
|
|
|
| 5770 |
843 |
GOx–Fe3O4@SHS |
|
|
|
|
|
|
|
|
It is therefore believed that by combining properties and functionalities of a wide range of available enzymes and nanozymes in the integrated system demonstrated herein would allow applications in biosensors, immunoassays, biofuel cells, and so forth. |
| 5773 |
845 |
CuS QDs/Co3O4 Polyhedra |
chlorpyrifos detection |
chlorpyrifos |
E-chem |
1 × 10^–1-1 × 10^7 |
ng mL–1 |
0.34 |
pg mL–1 |
98.27–103.47% |
|
| 5775 |
848 |
sulfuration-engineered CoOx |
alkaline phosphatase activity sensing |
Alkaline phosphatase (ALP) |
Color |
0.8-320 |
U/L |
0.38 |
U/L |
|
|
| 5776 |
849 |
DMNF/DMNS and MNFPPL |
stably deliver anticancer drug doxorubicin (DOX) into the tumor cells for pH/NIR-responsive chemotherapy, provid strong photoacoustic, photothermal performances and stimulated generation of reactive oxygen species (ROS) for imaging-guided PTT/PDT/CDT combined therapy. |
|
|
|
|
|
|
|
|
| 5780 |
853 |
Fe-CDs |
ratiometric fluorescence assay for L-Cystein |
L-Cysteine |
Fluor |
0.25-90 |
μM |
0.047 |
μM |
|
|
| 5781 |
854 |
CeO2/Pt@cZVs |
construct artificial peroxisomes (AP) which held a good therapeutic effect in ROS-induced ear-inflammation by resisting protein adsorption, endocytosing efficiently, and escaping from the lysosome. |
|
|
|
|
|
|
|
|
| 5782 |
855 |
FeS2@C NSs |
glucose detection |
glucose |
Color |
0.5-50 |
μM |
0.19 |
μM |
|
|
| 5783 |
855 |
FeS2@C NSs |
glucose detection |
H2O2 |
Color |
0.5-40 |
μM |
0.17 |
μM |
|
|
| 5785 |
857 |
Fe3O4@Au@cDNA@H-GN |
colorimetric biosensing of nopaline synthase terminator |
nopaline synthase terminator |
Color |
0.5-100 |
nM |
0.19 |
nM |
|
|
| 5787 |
859 |
Co3O4-g-C3N4 |
degradation of environmental rhodamine B |
|
|
|
|
|
|
|
|
| 5788 |
860 |
Au–Ag–GOx HTNs |
NIR-II driven plasmon-enhanced cascade reaction for tumor microenvironment-regulated catalytic therapy. |
|
|
|
|
|
|
|
|
| 5789 |
861 |
g-CNOX |
trigger luminol-H2O2 to produce a long-lasting and intense chemiluminescence emission |
|
|
|
|
|
|
|
|
| 5791 |
863 |
NER |
Coenhanced chemodynamic and starving therapy against tumor hypoxia and antioxidant defense system |
|
|
|
|
|
|
|
|
| 5793 |
865 |
Fe3O4@PPy MIPs |
reusibility |
|
|
|
|
|
|
|
|
| 5796 |
869 |
Ag-Pt/rGO |
a convenient and sensitive method for the colorimetric determination of hydrogen peroxide was developed |
H2O2 |
|
10-100 |
μM |
0.09 |
μM |
|
|
| 5801 |
875 |
DMSN-Au NP |
glucose oxidase by DMSN-Au NPs not only reduces the cost but also provides significantly amplified signals due to DMSNs haing a high specific surface area. We show the detection of carcinoembryonic antigen (CEA) as an example target to evaluate the analytical figure of merits of the proposed strategy. Under the optimal conditions, twophoton- based o-CDs displayed excellent performances for CEA |
|
|
0.1-80 |
ng/mL |
74.5 |
pg/mL |
|
|
| 5802 |
876 |
Co4S3/Co(OH)2 HNTs |
Owing to the outstanding oxidase-like activity, Co4S3/Co(OH)2 HNTs can eliminate Escherichia coli, Pseudomonas aeruginosa, Staphylococcus sciuri, and Bacillus without the help of H2O2. |
|
|
|
|
|
|
|
|
| 5806 |
880 |
Fe3O4@PAA/TMC/PEG |
sterilization |
E.coli and S.aureus bacteria. |
|
|
|
|
|
|
|
| 5810 |
884 |
NL-MnCaO2 |
confirmed the application of these compounds for the detection of glucose in human serum samples |
glucose |
|
|
|
6.12 |
nM |
|
|
| 5811 |
885 |
HGNs-Apt |
the current response of Ag had a good positive correlation with the GPC3 concentration |
Glypican-3 |
|
10.0–100.0 |
μg/mL |
3.16 |
μg/mL |
|
|
| 5812 |
886 |
Co3Fe-MMOF |
detection of Aeromonas hydrophila |
Aeromonas hydrophila |
Color |
62-6.2*108 |
CFU/mL |
17 |
CFU/mL |
60%-70% |
|
| 5819 |
901 |
DHPC@CS-AgNPs |
Detection of Hg2+ |
Hg2+ |
Color |
0.02-1 |
μM |
0.014 |
μg/mL |
|
|
| 5822 |
906 |
MNPs |
Detection |
E. coli membrane |
Color |
104–108 |
CFU/mL |
3.2 × 103 |
CFU/mL |
|
|
| 5825 |
909 |
Tungsten Disulfide Quantum Dots |
Detection of H2O2 |
H2O2 |
Color |
0.1–60 |
μM |
|
|
|
|
| 5826 |
910 |
hollow mesoporous silica nanosphere-supported nanosized platinum oxide |
evaluating its potential as chemotherapeutics |
H2O2 |
|
|
|
|
|
|
|
| 5828 |
914 |
MnO2@Au |
enhanced photothermal performance and reactive oxygen species generation |
tumour |
|
|
|
|
|
|
|
| 5830 |
917 |
BSA-MnO2/IR820@OCNC |
antitumor |
H2O2 |
|
|
|
|
|
|
|
| 5832 |
922 |
Ru/PC |
detection of H2O2 |
H2O2 |
Color |
0.005-2.75 |
mM |
3.8 |
μM |
|
|
| 5834 |
925 |
AuNPs |
Detection of Hg2+ |
Hg2+ |
Color |
0.4-15 |
μM |
0.147 |
μM |
|
|
| 5835 |
925 |
AuNPs |
Detection of Hg2+ |
Hg2+ |
Unsure |
0.4-8 |
μM |
0.06 |
μM |
|
|
| 5838 |
927 |
CHPB NPs |
Antibacterial |
We report for the first
time the dual modality antibacterial application of CHPB NPs
against both Gram-negative bacteria, Pseudomonas aeruginosa,
and Gram-positive bacteria, Staphylococcus aureus. |
|
|
|
|
|
|
|
| 5839 |
928 |
BLGF-Au NCs |
quantitative detection of glucose |
glucose |
Colorimetric |
5-100 |
μM |
1.5 |
μM |
|
|
| 5840 |
929 |
PVP-AuNPs |
quantitative detection of mercury |
mercury |
Colorimetric |
5-100 |
nM |
1.9 |
nM |
|
|
| 5843 |
933 |
Au-PDA-AAO |
quantitative detection of glucose |
glucose |
Colorimetric |
0.5-50 |
μM |
0.2 |
μM |
|
|
| 5844 |
934 |
FeP@C nanosheets |
quantitative detection of cysteine |
cysteine |
Colorimetric |
0.04-10 |
μM |
0.026 |
μM |
|
|
| 5846 |
936 |
Co3O4/NF |
treatment of organic pollutants |
|
|
|
|
|
|
|
|
| 5847 |
937 |
Au-NPs-Cy-PVA |
quantitative detection of iodide ions |
iodide ions |
Colorimetric |
0.12-5.42 |
μM |
0.058 |
μM |
|
|
| 5850 |
941 |
D-His@AuNCs |
quantitative detection of doxycycline |
doxycycline |
Colorimetric |
5.0-12.5 |
μM |
1.0 |
μM |
|
|
| 5851 |
942 |
AuNPs |
decomposition of residual H2O2 |
|
|
|
|
|
|
|
|
| 5852 |
943 |
PTAC-MoS2 NS |
quantitative detection of glucose |
glucose |
Colorimetric |
20-800 |
μM |
18.34 |
μM |
|
|
| 5854 |
945 |
Au-Hg/rGO |
quantitative detection of H2O2 |
H2O2 |
Colorimetric |
5-100 |
μM |
3.25 |
μM |
|
|
| 5856 |
951 |
LDH-MoS2 |
anticancer |
|
|
|
|
|
|
|
|
| 5857 |
952 |
Cu5.4O@Hep-PEG |
wound healing |
|
|
|
|
|
|
|
|
| 5867 |
964 |
CeO2-CDs |
Ratiometric fluor escence detection
of H 2 O 2 and cholesterol |
cholesterol |
Fluor |
1.66 -1.65 |
μ M-mM |
0.49 |
µM |
|
|
| 5868 |
965 |
Fe3O4@Au |
Detection of dopamine |
Dopamine (DA) |
E-chem |
0.01 – 1 |
mmol/L |
0.0109 |
mg/L |
|
|
| 5873 |
970 |
phosphorene@Ti3C2-MXene |
Sensing of
α -naphthalene acetic acid |
α -naphthalene acetic acid |
E-chem |
0.02 – 40 |
μ M |
1.6 |
nM |
|
|
| 5874 |
971 |
PdPtBP MNPs/MXene |
KIM-1 |
H2O2 |
|
0.5-100 |
ng/mL |
86 |
pg/mL |
|
|
| 5875 |
972 |
BSA@Au NPs |
CYFRA21-1 detection |
glucose |
E-chem |
0.1-50 |
ng/mL |
1.12 |
fg/mL |
|
|
| 5876 |
973 |
Fe3O4@SiO2-NH2-Au@Pd0.30NPs-protG |
antip53aAbs detetion |
anti-p53aAbs |
Color |
1-500 |
ng/mL |
15 |
pg/mL |
|
|
| 5883 |
980 |
CNQDs@MA-Ag |
Hg2+ sensing |
TMB |
Color |
0.010-25 |
μM |
0.050 |
nM |
|
|
| 5884 |
981 |
FePd |
RhB degradation |
TMB |
Color |
|
|
|
|
|
|
| 5886 |
983 |
FeP-pSC4-AuNPs |
H2O2 detection |
ABTS |
Color |
|
|
|
|
|
|
| 5888 |
984 |
Cu-NC |
Glucose detction |
glucose oxidase |
Color |
0.1-400 |
|
100 |
nM |
|
|
| 5887 |
984 |
Cu-NC |
H2O2 detection |
TMB |
Color |
0.01-100 |
|
10 |
nM |
|
|
| 5889 |
984 |
Cu-NC |
Ascorbic acid detction |
Ascorbic acid (AA) |
Color |
0.1-500 |
|
90 |
nM |
|
|
| 5890 |
986 |
SA-Fe/NG |
detection of Cr5+ |
Cr4+ |
Color |
30-3000 |
nM |
3 |
nM |
101.52%-113.67% |
|
| 5899 |
992 |
Fe3O4@Pt@E5 |
AML treatment |
|
|
|
|
|
|
|
|
| 5906 |
999 |
CS@GSH-CuNCs |
detection of choline |
|
Color |
20-150 |
μM |
6.5 |
μM |
|
|
| 5908 |
999 |
CS@GSH-CuNCs |
detection of AChE activity. |
|
Color |
10-120 |
mU/mL |
3.3 |
mU/mL |
|
|
| 5907 |
999 |
CS@GSH-CuNCs |
detection of choline |
|
Fluor |
5-100 |
μM |
1.2 |
μM |
|
|
| 5909 |
999 |
CS@GSH-CuNCs |
|
|
Fluor |
5-100 |
mU/mL |
1.4 |
mU/mL |
|
|
| 5912 |
1004 |
Au/BiVO4 |
Detection of Glucose |
Glucose |
E-chem |
0.001 -1000 |
μM |
2.6*10-4 |
μM |
|
|
| 5916 |
1007 |
AuNF-Ce6 |
cancer therapy |
|
|
|
|
|
|
|
|
| 5920 |
1013 |
GNF |
Detection of Dopamine |
Dopamine (DA) |
Color |
|
|
4.5 |
μg/mL |
99.53-101.13% |
|
| 5921 |
1013 |
GNF |
Detection of Catechol |
Catechol |
Color |
|
|
3.0 |
μg/mL |
98.75-101.13% |
|
| 5922 |
1013 |
GNF |
Detection of Hydroquinone |
Hydroquinone |
Color |
|
|
4.5 |
μg/mL |
98.36-100.39% |
|
| 5923 |
1014 |
CTNs |
epinephrine detection |
epinephrine |
Color |
4.5-90 |
μM |
3.4 |
μM |
|
|
| 5926 |
1017 |
Pd-Ir nanocubes |
immunoassay of nucleocapsid protein from SARS-CoV-2 |
NP |
Color |
|
|
0.023 |
ng/mL |
|
|
| 5927 |
1017 |
Pd-Ir nanocubes |
immunoassay of nucleocapsid protein from SARS-CoV-2 |
PSA |
Color |
|
|
0.348 |
pg/mL |
|
|
| 5928 |
1018 |
gold nanozymes |
cleave quite efficiently nerve agent simulants PNPDPP and DMPN as Zn(II) and Cu(II) complexes at room temperature and physiological pH |
|
|
|
|
|
|
|
|
| 5929 |
1020 |
CeO2/Tb2+ |
optical spectroscopy |
|
|
|
|
|
|
|
|
| 5930 |
1021 |
BPNs-Arg-GOx@MnO2 (BAGM) |
In summary, we have successfully structured a TME-activatable BAGM nanozyme for an MR/US imaging-guided multimodal synergistic therapy nanoplatform with PTT/starvation therapy/NO gas therapy |
|
|
|
|
|
|
|
|
| 5934 |
1026 |
dsDNA-AuNP@MABs |
determination of acetamiprid. |
acetamiprid |
Color |
0.4-4.5 |
ppb |
0.24 |
ppb |
|
|
| 5935 |
1027 |
Cr@Ag NP |
Determination of Hg2+ |
Hg2+ |
Color |
|
|
5 |
nM |
|
|
| 5936 |
1028 |
integrating CuO/g-C3N4 p-n heterojunctioned photoactive material with MoS2 QDs@Cu NWs multifunction signal amplifier |
Aptasensing of AβO in human serum |
AβO |
E-chem |
10
fM to 0.5 μM |
|
5.79 |
fM |
|
|
| 5937 |
1029 |
CNCs@AuNPs |
catalyzing the reduction of hydrogen peroxide (H2O2) to initiate a characteristic color reaction at acidic pH and the disproportionation of O2•− producing O2 and H2O2 at alkaline pH, respectively |
|
|
|
|
|
|
|
|
| 5938 |
1030 |
Se@PDA@Bor |
multitargets synergistic therapy of AD |
|
|
|
|
|
|
|
|
| 5939 |
1031 |
bioconjugated nanoflowers |
Detection of Glucose |
Glucose |
Fluor |
0.2-300 |
mg/dl |
|
|
|
|
| 5940 |
1033 |
PtPB |
treat complex tumor diseases |
|
|
|
|
|
|
|
|
| 5944 |
1038 |
Fe3O4@MIL-100(Fe)-Au |
detection of H2O2 |
H2O2 |
Color |
|
|
|
|
|
|
| 5945 |
1039 |
Cu-PBG |
kill Gram-positive and Gram-negative bacteria with the assistance of H2O2 both in vitro and in vivo |
|
|
|
|
|
|
|
|
| 5946 |
1041 |
Mn3O4 NPs and NC |
Mn3O4 NPs and NC can be used as PPO mimics in the potential fields such as biosensing and removal of phenolic compounds in industrial waste waters. |
|
|
|
|
|
|
|
|
| 5948 |
1043 |
Ch-MoS2-Au@Pt |
specific biorecognition and catalyzed reduction of H2O2 |
H2O2 |
E-chem |
1 × 10− 4 -200 |
ng mL− 1 |
|
|
|
|
| 5949 |
1044 |
GSH-Au/Pt NCs |
Colorimetric detection of Cys |
cysteine |
Color |
0.5 to 30 |
μM |
0.154 |
μM |
|
|
| 5952 |
1046 |
Au/Ni-Fe LDH/rGO |
SERS sensing of Hg2+ |
Hg2+ |
Color |
0.01-0.20 |
μM |
0.01 |
μM |
|
|
| 5953 |
1046 |
Au/Ni-Fe LDH/rGO |
SERS sensing of MeHg |
MeHg |
Color |
0.01-0.10 |
μM |
0.01 |
μM |
|
|
| 5954 |
1046 |
Au/Ni-Fe LDH/rGO |
total removal of organic mercury |
|
|
|
|
|
|
|
|
| 5956 |
1048 |
CuCo(O)/GOx@PCNs |
Immunotherapy/Enhanced Starvation/Photothermal Therapy |
|
|
|
|
|
|
|
|
| 5963 |
1054 |
Zn-MnO2 |
protects pre-osteoblasts against H2O2-induced oxidative stress |
|
|
|
|
|
|
|
|
| 5966 |
1058 |
MoS2@CoFe2O4 |
determination of cysteine (Cys) |
Cys |
Color |
0.5-15 |
μM |
0.10 |
μM |
95.3% and 96.0% with the RSD of 2.1% and 4.2% |
|
| 5967 |
1058 |
MoS2@CoFe2O4 |
determination of glutathione (GSH) |
GSH |
Color |
0.5-35 |
μM |
0.21 |
μM |
|
|
| 5971 |
1061 |
apt-Fe3O4/MnO2 |
simultaneous detection of four foodborne pathogenic bacteria |
S. aureus |
Color |
1.0×10-1.0 × 10^6 |
CFU·mL−1 |
1.3 |
CFU·mL−1 |
|
|
| 5972 |
1061 |
apt-Fe3O4/MnO2 |
simultaneous detection of four foodborne pathogenic bacteria |
L. monocytogenes |
Color |
1.0×10-1.0 × 10^6 |
CFU·mL−1 |
1.2 |
CFU·mL−1 |
|
|
| 5973 |
1061 |
apt-Fe3O4/MnO2 |
simultaneous detection of four foodborne pathogenic bacteria |
E. coli O157:H7 |
Color |
1.0×10-1.0 × 10^6 |
CFU·mL−1 |
1.3 |
CFU·mL−1 |
|
|
| 5974 |
1061 |
apt-Fe3O4/MnO2 |
simultaneous detection of four foodborne pathogenic bacteria |
V. parahaemolyticus |
Color |
1.0×10-1.0 × 10^6 |
CFU·mL−1 |
1.4 |
CFU·mL−1 |
|
|
| 5975 |
1062 |
Fenozymes |
Superoxide Scavengers |
|
|
|
|
|
|
|
|
| 5977 |
1064 |
Pt-LNT NCs |
detection of glucose |
glucose |
Color |
5-1000 |
μM |
1.79 |
μM |
|
|
| 5978 |
1065 |
GCDs |
glucose detection |
glucose |
Color |
0-40 |
μM |
0.5 |
μM |
|
|
| 5979 |
1066 |
polyzymes |
Intracellular Activation of Anticancer Therapeutics |
|
|
|
|
|
|
|
|
| 5980 |
1067 |
BNQDs/CeO2 |
detection of kanamycin |
kanamycin |
Color |
0.01-100 |
nM |
4.6 |
pM |
|
|
| 5981 |
1068 |
SiO2@Pt NPs |
detection of mercury ions |
Hg2+ |
Color |
0.005-5000 |
nM |
60 |
fM |
|
|
| 5983 |
1070 |
1-M |
a versatile redox-catalysis platform |
|
|
|
|
|
|
|
|
| 5984 |
1072 |
Co(OH)2/FeOOH/WO3 |
detection of human cervical cancer cells |
HeLa cancer cells |
Color |
50-50000 |
cells/mL |
12 |
cells/mL |
|
|
| 5992 |
1083 |
MFNCDs |
detect Glucose |
H2O2 |
Color |
100 nM – 2 mM |
|
84 |
nM |
|
|
| 5993 |
1083 |
MFNCDs |
detect Glucose |
glucose |
Color |
500 nM – 1 mM |
|
0.41 |
μM |
|
|
| 5994 |
1083 |
MFNCDs |
detect Glucose |
H2O2 |
Fluor |
100 nM – 2 mM |
|
97 |
nM |
|
|
| 5995 |
1083 |
MFNCDs |
detect Glucose |
glucose |
Fluor |
500 nM – 1 mM |
|
0.85 |
μM |
|
|
| 5997 |
1085 |
Ni3S2/Cu1.8S@HA |
Anti-tumor activity |
|
|
|
|
|
|
|
|
| 5999 |
1088 |
PAN/FeNPs/NFs |
antibacterial |
|
|
|
|
|
|
|
|
| 6000 |
1092 |
SnO2/GCN |
detect H2O2 |
H2O2 |
Color |
10-655 |
μM |
0.3 |
μM |
|
|
| 6001 |
1093 |
MVCM@Pt |
detect visfatin |
visfatin |
Color |
1-100 |
ng/mL |
0.11 |
ng/mL |
|
|
| 6002 |
1094 |
Cu(II)-rGO |
detect Salmonella spp. |
Salmonella spp. |
Color |
1.93*10^1 - 1.93 *10^5 |
CFU/ml |
0.51 |
CFU/ml |
102.84-112.25% |
|
| 6003 |
1095 |
GOQD-q-CuO |
detect glucose |
H2O2 |
Color |
2.5–200 |
μM |
0.5 |
μM |
|
|
| 6004 |
1095 |
GOQD-q-CuO |
detect glucose |
glucose |
Color |
5–400 |
μM |
2.5 |
μM |
|
|
| 6005 |
1096 |
CDs@ZIF-8 |
detect GSH |
GSH |
Color |
0-100 |
μM |
1.04 |
μM |
|
|
| 6006 |
1096 |
CDs@ZIF-8 |
detect GSH |
H2O2 |
Color |
0.1-1.0 |
mM |
3.6 |
μM |
|
|
| 6008 |
1101 |
A/A-ES |
enhance the HS-PDT efficacy with the high efficiency in improving HS morphology and promoting HSF apoptosis and collagen rearrangement |
|
|
|
|
|
|
|
|
| 6009 |
1102 |
Pt/UiO-66 |
detect glucose |
glucose |
Color |
0.1−1.33 |
mM |
0.033 |
mM |
|
|
| 6016 |
1109 |
Fe/NPC |
sensitively determining acetylcholinesterase (AChE) |
acetylcholinesterase (AChE) |
Color |
0.02-5.0 |
U/L |
0.0073 |
U/L |
|
|
| 6017 |
1109 |
Fe/NPC |
sensitively determining acetylcholinesterase (AChE) |
acetylcholinesterase (AChE) |
Fluor |
0.01–5.0 |
U/L |
0.0032 |
U/L |
|
|
| 6019 |
1111 |
MoSe2/CoSe2@PEG |
for NIR-Enhanced Chemodynamic Therapy |
|
|
|
|
|
|
|
|
| 6021 |
1113 |
H-Gr@PdPtNPs |
electrochemical aptansensor for mucin 1 |
mucin 1 |
E-chem |
8.0pg/mL-80 ng/Ml |
|
2.5 |
pg/mL |
|
|
| 6024 |
1117 |
CCN |
Catalytic Click Immunoassay of Foodborne Pathogens |
Salmonella enteritidis |
Fluor |
100–1000000 |
CFU/mL |
11 |
CFU/mL |
|
|
| 6026 |
1119 |
N/I-CDs |
photocatalytic antibacterial and wound disinfection |
|
|
|
|
|
|
|
|
| 6027 |
1120 |
ZnO-Co3O4 NCs |
Colorimetric determination of amyloid-β peptide |
Aβ monomer |
Color |
5-150 |
nM |
3.5 |
nM |
|
|
| 6032 |
1128 |
ZnSA-AuAMP hydrogel |
detection of ALP |
Alkaline phosphatase (ALP) |
Color |
0.47-10.03 |
U/L |
0.09 |
U/L |
|
|
| 6033 |
1129 |
Co–Fe@hemin |
detection of SARS-CoV-2 antigen |
SARS-CoV-2 antigen |
Color |
0.2-100 |
ng/mL |
0.1 |
ng/mL |
|
|
| 6034 |
1130 |
CuS/g-C3N4 |
Ibuprofen can be detected |
Ibuprofen |
Color |
0-100 |
mg/L |
21.20 |
mg/L |
|
|
| 6035 |
1130 |
CuS/h-BN |
Ibuprofen can be detected |
Ibuprofen |
Color |
0-100 |
mg/L |
16.01 |
mg/L |
|
|
| 6039 |
1136 |
MPG |
MPG-based synergetic CDT/SDT/starvation therapy |
|
|
|
|
|
|
|
|
| 6040 |
1137 |
Se@Me@MnO2 NPs |
resisting ROS-mediated damage, thereby alleviating the inflammation |
|
|
|
|
|
|
|
|
| 6041 |
1138 |
AOX–CF–H-Au |
detection to ethanol |
ethanol |
E-chem |
0.01–0.15 |
mM |
0.005 |
mM |
|
|
| 6042 |
1138 |
GOX–CF–H-Au |
detection to glucose |
glucose |
E-chem |
0.1–0.9 |
mM |
0.05 |
mM |
|
|
| 6046 |
1149 |
SrTiO3/DHB |
Amplified detection of G-6-P and G6PD |
G6PD |
Color |
1.4 × 10–5–14 |
U/mL |
5.7 × 10–6 |
U/mL |
|
|
| 6047 |
1149 |
SrTiO3/DHB |
Amplified detection of G-6-P and G6PD |
G-6-P |
Color |
0.05–100 |
μM |
0.016 |
μM |
99.3%-103.0% |
G-6-P in spiked serum sample |
| 6048 |
1151 |
Fe-CoO NCs |
a facile and sensitive colorimetric sensor to detect H2O2 and dopamine (DA) |
H2O2 |
Color |
6–20 |
μM |
4.40 |
μM |
97.6-106.4% |
|
| 6049 |
1151 |
Fe-CoO NCs |
a facile and sensitive colorimetric sensor to detect H2O2 and dopamine (DA) |
Dopamine (DA) |
Color |
2–10 |
μM |
1.99 |
μM |
94.6–107.2% |
|
| 6051 |
1156 |
Fe3O4/CeO2/C-dot nanocomposite |
H2O2 detection |
H2O2 |
Color |
5.0 × 10^–13–1.0 × 10^–6 |
M |
5.0 × 10^–13 |
M |
|
|
| 6054 |
1159 |
CeO2@C |
antifouling |
|
|
|
|
|
|
|
|
| 6055 |
1161 |
SF@Rsg-Mn |
Synergistic Treatment of Obesity |
|
|
|
|
|
|
|
|
| 6057 |
1164 |
GOx@Fe-MMPG-5 |
sensing of glucose |
glucose |
Color |
0–350 |
μM |
0.5 |
μM |
|
|
| 6058 |
1164 |
GOx@Fe-MMPG-5 |
Determination of cholesterol |
cholesterol |
Color |
2-300 |
μM |
|
|
|
|
| 6063 |
1169 |
GK-Pd NPs |
selective and sensitive detection of cholesterol |
cholesterol |
Color |
5-100 |
μM |
3.7 |
μM |
|
|
| 6066 |
1174 |
AS1411-PtNPs |
sensitive and wide-range detection of cancer cells |
cancer cells |
Color |
25-20000 |
cells/mL |
10 |
cells/mL |
95.0% to 104.0% |
|
| 6067 |
1175 |
Fe3O4@MnO2 |
colorimetric determination of glutathione |
glutathione |
Color |
0.2-25 |
μM |
0.2 |
μM |
|
|
| 6068 |
1178 |
nano-Pt/VP@Mlipo |
targeted cancer chemophototherapy |
|
|
|
|
|
|
|
|
| 6070 |
1180 |
Heme-AuNPs |
served as a Cys colorimetric sensor, detect cysteine |
Cys |
Color |
15~750 |
nM |
10 |
nM |
|
|
| 6072 |
1183 |
Gd@PANs |
NIR photo-activated synergistic photothermal-chemodynamic cancer therapy |
|
|
|
|
|
|
|
|
| 6073 |
1184 |
PINMH |
enhanced photo-gas therapy and real-time tracking |
|
|
|
|
|
|
|
|
| 6076 |
1188 |
PAA–CeO2 |
chemiluminescent detection of prostate specific antigen |
prostate specific antigen |
CL |
0.0001-10 |
ng/mL |
0.053 |
pg/mL |
|
|
| 6077 |
1189 |
W/GCN |
fluorescence quenching mediated detection of hydrogen peroxide |
H2O2 |
Fluor |
10-500 |
nM |
8 |
nM |
|
|
| 6078 |
1189 |
W/GCN |
fluorescence quenching mediated detection of hydrogen peroxide |
H2O2 |
Color |
35-400 |
nM |
20 |
nM |
|
|
| 6079 |
1190 |
ATP-HCNPs@Ce6 |
tumor synergistic phototherapy |
|
|
|
|
|
|
|
|
| 6080 |
1191 |
PdCo@MSNs |
Colorimetric detection of GSH |
glutathione |
Color |
2-20 |
μM |
0.33 |
μM |
|
|
| 6081 |
1192 |
M@NxCy |
facile methane activation |
|
|
|
|
|
|
|
|
| 6082 |
1193 |
rGO/CMCNs |
colorimetric detection of neurotransmitter dopamine in blood serum and urine samples |
Dopamine (DA) |
Color |
1-10 |
μM |
0.17 |
μM |
|
|
| 6083 |
1194 |
Pt/NiCo-LDH NCs |
Fast colorimetric sensing of H2O2 and glutathione |
H2O2 |
Color |
10-90 |
mM |
0.76 |
mM |
|
|
| 6084 |
1194 |
Pt/NiCo-LDH NCs |
Fast colorimetric sensing of H2O2 and glutathione |
glutathione |
Color |
50-500 |
mM |
3.77 |
mM |
|
|
| 6087 |
1200 |
Au/CeO2 core/shell NPs |
Au/CeO2 core-shell nanoparticles allow the utilization of visible light
Page 1 of 24 Nanoscale
Nanoscale Accepted Manuscript
Published on 07 December 2020. Downloaded by University of Western Ontario on 12/20/2020 7:21:12 PM.
View Article Online
DOI: 10.1039/D0NR06356H
2
for photoelectrochemical hydrogen peroxide (H2O2) detection with improved
sensitivity under white light illumination or application of such particles |
H2O2 |
|
up to 2000 |
μM |
3 |
μM |
|
photoelectrochemical |
| 6088 |
1201 |
UMONs-LA-Au |
promoted the oxidation of LA for an improved NO yield, which led to significant nanocatalysis-enhanced NO gas therapy for tumor eradication |
|
|
|
|
|
|
|
|
| 6090 |
1205 |
Hem@Gel |
Enhancing the peroxidase-mimicking activity of hemin |
|
|
|
|
|
|
|
|
| 6091 |
1206 |
Cu–Ru/LIG |
detection of H2O2 |
H2O2 |
|
10-4320 |
µM |
1.8 |
µM |
|
|
| 6092 |
1207 |
Hemin-doped HKUST-1/rGO |
The
Hemin-doped HKUST-1/rGO nanozyme showed an excellent electrocatalytic activity for DA oxidation,
which is due to the enhanced Hemin activity through the formation of a metal–organic framework
(MOFs) and the synergy between the Hemin-doped HKUST-1 and rGO in nanozyme |
DA |
|
0.03–10 |
μM |
3.27× 10-8 |
M |
|
|
| 6097 |
1217 |
B-Doped core–shell Fe@BC nanozymes |
combat bacteria |
|
|
|
|
|
|
|
|
| 6098 |
1219 |
MnO2 NSs–TMB |
glucose colorimetric detection system |
glucose |
Color |
0-4000 |
μM |
5.0 |
μM |
|
|
| 6100 |
1222 |
Vo-CNPLs with P-Ce3+ ions |
anti-cancer therapy |
|
|
|
|
|
|
|
|
| 6104 |
1225 |
di-DNA/CuO |
targeted delivery and selective tumor destruction |
|
|
|
|
|
|
|
|
| 6106 |
1228 |
Pt@polydopamine |
Pt catalyst to relieve tumour hypoxia in photodynamic therapy |
|
|
|
|
|
|
|
|
| 6112 |
1240 |
Cu-CDs |
Cr(III) detection |
Cr(III) |
Fluor |
5×10^-6-1.5×10^-4 |
mol/L |
1.2×10^-7 |
mol/L |
|
|
| 6113 |
1241 |
Au@NH2-MIL-125(Ti) |
Determination of Cysteine in fetal bovine serum |
Cysteine |
Color |
1-10 |
μM |
0.15 |
μM |
|
|
| 6114 |
1242 |
MoS2@Au |
Salmonella typhimurium detection |
Salmonella typhimurium |
Color |
10^2-10^7 |
lg (CFU/mL) |
100 |
lg (CFU/mL) |
84.34 ± 5.90 % (n = 3) to 118.92 ± 3.61 % (n = 3) |
|
| 6116 |
1244 |
Au-MCM-41 hybrids |
Multiple reaction conditions have been thoroughly explored to identify the best performing scenario and the main reaction products (i.e., gluconic acid and hydrogen peroxide) expected from the selective oxidation of glucose. |
|
|
|
|
|
|
|
|
| 6118 |
1248 |
Fe3O4@PDA@Pd/Pt |
HCG, a clinic marker of
pregnancy |
HCG |
Color |
0.01-4 |
mIU/mL |
0.0094 |
mIU/mL |
|
|
| 6119 |
1248 |
Fe3O4@PDA@Pd/Pt |
E. coli O157:H7 |
E. coli O157:H7, one of the important foodborne pathogens |
Color |
100-100000 |
(CFU/mL |
90 |
(CFU/mL |
|
|
| 6121 |
1251 |
BiOBr/PtRu |
Detection of Fe2+ |
Fe2+ |
Color |
0.5-3 |
mM |
|
|
|
|
| 6122 |
1253 |
CuxO@EM-K |
Selective and Synergistic Clearance of Peripheral Amyloid-β in an Alzheimer’s Disease Model |
|
|
|
|
|
|
|
|
| 6123 |
1255 |
Prussian Blue nanoparticles |
100-Fold Greater Bimolecular Rate Constants Compared to Those of the Enzyme |
|
|
|
|
|
|
|
|
| 6124 |
1256 |
Fe2O3@PSC |
prevent osteoporosis |
|
|
|
|
|
|
|
|
| 6128 |
1262 |
PDA-Fe(III) NPs |
quantitative detection of prostate-specific antigen (PSA) |
PSA |
colorimetric immunoassay |
0.5-20000 |
pg/mL |
0.84 |
pg/mL |
|
|
| 6131 |
1265 |
C-AuNPs |
quantitative detection of OPs |
Parathion-Ethyl |
colorimetric |
11.65-93.2 |
ng/mL |
5.8 |
ng/mL |
|
|
| 6132 |
1266 |
BC@DNA-Mn3(PO4)2/SPCE |
in situ detection of O2•− |
|
Unsure |
34.7-7000 |
nM |
5.87 |
nM |
|
|
| 6133 |
1268 |
H2TCPP/ZnS/CoS |
quantitative detection of Hg2+ |
Hg2+ |
colorimetric |
40−1000 |
nM |
17.74 |
nM |
|
|
| 6134 |
1269 |
Ab-GNPs-Cu(II) |
quantitative detection of Endothelin‑1 |
Endothelin‑1 |
electrochemical immunoassay |
0.5-500 |
ng/mL |
100 |
pg/mL |
|
|
| 6135 |
1273 |
DNA–AuNPs |
quantitative detection of Hg2+ |
Hg2+ |
Colorimetric |
0.05-2 |
μM |
10 |
nM |
|
|
| 6136 |
1274 |
IrO2/MnO2 |
quantitative detection of ascorbic acid |
Ascorbic acid (AA) |
Colorimetric |
0–312.5 |
μM |
1.23 |
μM |
|
|
| 6137 |
1276 |
MnO2- and SiO2@Fe3O4 |
quantitative detection of H2O2 |
H2O2 |
Colorimetric |
1.0-100.0 |
μM |
0.26 |
μM |
|
|
| 6138 |
1277 |
Cu2+/PPy NTs |
quantitative detection of H2O2 |
H2O2 |
Colorimetric |
4-100 |
μM |
1.62 |
μM |
98.5%–104.4% |
|
| 6139 |
1278 |
Pt/CeO2/NCNFs |
quantitative detection of H2O2 |
H2O2 |
electrochemical |
0.0005–15 |
mM |
0.049 |
μM |
|
|
| 6140 |
1279 |
GO/AuNPs |
colorimetric analysis of DNA |
DNA |
Colorimetric |
0.04-120 |
nM |
8.8 |
pM |
|
|
| 6142 |
1281 |
CD N/Au |
selective detection of ultratrace K+ |
K+ |
Fluor |
0.06–1.3 |
nM |
0.024 |
nM |
|
|
| 6146 |
1285 |
Bi@PVP@AuPt NPs |
cancer treatment and diagnostic applications |
|
|
|
|
|
|
|
|
| 6150 |
1292 |
0.10CeO2/CoO NCs |
human Urine |
L-cystein sensing |
Color |
5-10 |
μM |
3.71 |
μM |
|
|
| 6154 |
1302 |
ITO/CMC-PPy-PB/GOx |
Amperometric detection of glucose and H2O2 |
H2O2 |
E-chem |
5- 470 |
μM |
0.59 |
μM |
|
|
| 6155 |
1302 |
ITO/CMC-PPy-PB/GOx |
Amperometric detection of glucose and H2O2 |
|
E-chem |
0.02-1.1 |
mM |
5.23 |
μM |
|
|
| 6157 |
1304 |
Ag2S@Fe2C-DSPE-PEG-iRGD |
Therapy for breast cancer |
TMB |
Color |
|
|
|
|
|
|
| 6159 |
1306 |
CeO2 NRs@polymer |
Catalytically Generate Oxidative Stress for Tumor Therapy |
Tumor |
Resonance Raman |
|
|
|
|
|
|
| 6162 |
1309 |
Au NPs@GQDs |
Determination of quercetin in human plasma |
Quercetin |
E-chem |
1.0×10^(−10)-1.0×10(−3) |
mol/L |
3.3*10(-11) |
M |
|
|
| 6165 |
1312 |
CeO2 NPs@polymer |
To deplete reactive oxygen species (ROS) |
ROS |
Fluor |
|
|
|
|
|
|
| 6167 |
1314 |
Pt NPs |
Detection of mercury in environmental water samples |
Mercury |
E-chem |
|
|
|
|
|
|
| 6179 |
1330 |
CWNSs |
detection of H2O2 |
H2O2 |
Color |
0.5-100 |
μM |
0.15 |
μM |
|
|
| 6185 |
1337 |
Au@CeO2 |
photothermal/oxygen-enriched combination therapy for RA |
|
|
|
|
|
|
|
|
| 6186 |
1340 |
V2O5-Mt |
detection of H2O2 |
H2O2 |
Color |
30-400 |
μM |
4.0 |
μM |
|
|
| 6187 |
1340 |
V2O5-Mt |
detection of GSH |
GSH |
Color |
0.1-30 |
μM |
0.069 |
μM |
|
|
| 6190 |
1342 |
AgNPs@GQDs |
detection of H2O2 |
H2O2 |
Color |
0.08-40 |
μM |
0.025 |
μM |
|
|
| 6191 |
1342 |
AgNPs@GQDs |
detection of H2O2 |
H2O2 |
Fluor |
2-60 |
μM |
0.83 |
μM |
|
|
| 6192 |
1342 |
AgNPs@GQDs |
detection of glucose |
glucose |
Color |
0.5-50 |
μM |
0.17 |
μM |
92.89%–104.44% |
|
| 6193 |
1342 |
AgNPs@GQDs |
detection of glucose |
glucose |
Fluor |
5-100 |
μM |
1.31 |
μM |
|
|
| 6195 |
1345 |
BSA-MnO2 NPs |
In vitro antioxidant |
|
|
|
|
|
|
|
|
| 6197 |
1347 |
ZIF-67@PDA |
determination of Escherichia coli O157:H7 |
Escherichia coli O157:H7 |
Color |
30-3.0×10^8 |
CFU/mL |
12 |
CFU/mL |
|
|
| 6198 |
1348 |
NG@NC |
nonenzymatic electrochemical sensing for H2O2 |
H2O2 |
E-chem |
0.05-30 |
mM |
29 ± 2 |
μM |
|
|
| 6206 |
1356 |
PB@Ti3C2Tx |
Hydrogen Peroxide and Pesticide Sensing |
H2O2 |
Color |
2-100,100-240 |
μM |
0.4667 |
μM |
|
|
| 6207 |
1356 |
PB@Ti3C2Tx |
Hydrogen Peroxide and Pesticide Sensing |
Dopamine (DA) |
Color |
5-120 |
μM |
3.36 |
μM |
|
|
| 6208 |
1356 |
PB@Ti3C2Tx |
Hydrogen Peroxide and Pesticide Sensing |
glucose |
Color |
10-350 |
μM |
6.52 |
μM |
|
|
| 6209 |
1356 |
PB@Ti3C2Tx |
Hydrogen Peroxide and Pesticide Sensing |
malathion |
E-chem |
1×10^(-15)-1×10^(-9) |
M |
1.3×10^(-16) |
M |
|
|
| 6210 |
1357 |
SA-PtNPs |
Antioxidant Capacity and Analysis of Proanthocyanidins |
oligomeric proanthocyanidins |
Color |
4-32.5 |
μM |
2.0 |
μM |
|
|
| 6214 |
1361 |
R-MnCo2O4/Au NTs |
fluoride detection |
F- |
SERS |
0.1 to 10 |
nM |
0.1 |
nM |
|
|
| 6215 |
1362 |
MSF nanostructures |
Detection of Glucose |
glucose |
Color |
1.4-86 |
μM |
0.5 |
μM |
|
|
| 6217 |
1364 |
PPy@CoO/NiO NTs |
detect AA |
AA |
Color |
0.5-40 |
μM |
0.183 |
μM |
|
|
| 6218 |
1364 |
PPy@CoO/NiO NTs |
detect H2O2 |
H2O2 |
Color |
4-60 |
μM |
2.62 |
μM |
|
|
| 6219 |
1365 |
Fe3O4@C/Ni |
colorimetric assay for cholesterol determination |
cholesterol |
Color |
5-200 |
μM |
0.17 |
μM |
|
|
| 6220 |
1365 |
Fe3O4@C/Ni |
colorimetric assay for cholesterol determination |
H2O2 |
Color |
1-50 |
μM |
48 |
nM |
|
|
| 6221 |
1367 |
AgNPs@rGO |
detect glucose |
glucose |
Color |
125-1000 |
μM |
40 |
μM |
|
|
| 6222 |
1367 |
AgNPs@rGO |
detect glucose |
H2O2 |
Color |
|
mM |
20 |
μM |
|
|
| 6227 |
1373 |
中空 Fe3O4-PB 复合纳米粒类 Fenton 催化降解苯酚 |
催化降解苯酚 |
Phenol |
Color |
|
|
|
|
|
|
| 6229 |
1375 |
四氧化三铁和普鲁士蓝 |
调节卵巢癌细胞干性 |
|
|
|
|
|
|
|
|
| 6231 |
1377 |
Au@Pt/MIL-101(Cr) |
electrochemical aptasensor for OTA detection. |
ochratoxin A |
E-chem |
0.001-5 |
ng/mL |
0.17 |
pg/mL |
|
|
| 6232 |
1378 |
PAA-Cnp |
membrane disruption-based bactericidal activity against a broad spectrum of pathogenic as well as biofilm-encased bacteria |
|
|
|
|
|
|
|
|
| 6234 |
1380 |
GI-Au NZ |
effectively prevent serial passage-induced senescence in nHDFs, as well as oxidative stress in mice skin, suggesting a range of strategies to further develop novel therapeutics for acute frailty |
|
|
|
|
|
|
|
|
| 6235 |
1382 |
Cu-MOP |
Responsive Cytoprotective Shell for Living Cell Encapsulation |
|
|
|
|
|
|
|
|
| 6236 |
1383 |
SWCNT-CO- (APy)6[H2W12O40] |
Detection of Hydrogen Peroxide |
|
|
0.1-0.8 |
mM |
0.4 |
μM |
|
|
| 6237 |
1384 |
CoxOyHz@ZIF-67 |
glucose determination in human serum samples |
glucose |
A differential photoelectrochemical (PEC) method |
0.1-1000 |
μM |
0.03 |
μM |
|
|
| 6238 |
1384 |
CoxOyHz@ZIF-67/TiO2 NTs |
H2O2 determination |
H2O2 |
|
0.01-1000 |
μM |
5 |
nM |
|
|
| 6240 |
1386 |
PDI/CeO2 NR |
Detection of H2O2 |
H2O2 |
Color |
10-500 |
μM |
2.23 |
μM |
|
|
| 6241 |
1386 |
PDI/CeO2 NR |
Detection of AA |
AA |
Color |
0.5-50 |
μM |
0.68 |
μM |
|
|
| 6243 |
1389 |
Fe3O4@Cu/C and Fe3O4@CuO |
oxidative degradation of model organic dyes (MB) |
organic dyes (MB) |
Color |
|
|
|
|
|
|
| 6244 |
1391 |
Ag/PANI |
glucose determination in human serum samples |
glucose |
Color |
|
|
|
|
|
|
| 6246 |
1395 |
luminol-Ga |
detection of Ppi |
PPi |
Color |
0.5-15 |
μM |
62.4 |
nM |
98.2 % - 102.6 % and 97.3 % - 101.3 % in local lake water and tap water samples |
|
| 6249 |
1398 |
HSA@PDA/Fe NCs |
detection of H2O2 |
H2O2 |
Color |
0.5-100 |
μM |
0.06 |
μM |
|
|
| 6252 |
1402 |
Hb–Cu3(PO4)2 NFs |
Detection of Thiamine |
Thiamine |
Fluor |
0.05-50 |
μM |
0.048 |
μM |
|
|
| 6253 |
1403 |
Au@FeP |
detection of Fe2+ |
Fe2+ |
Color |
|
|
0.41 |
μM |
|
|
| 6254 |
1405 |
NiFe2O4–PANI |
Sensing Ascorbic acid |
Ascorbic acid (AA) |
Color |
10-100 |
μM |
232 |
nM |
|
|
| 6255 |
1405 |
NiFe2O4–PANI |
Sensing Ascorbic acid |
Ascorbic acid (AA) |
E-chem |
0.1-1 |
μM |
423 |
nM |
|
|
| 6256 |
1405 |
NiFe2O4–PANI |
Sensing H2O2 |
|
Color |
|
|
132 |
nM |
|
|
| 6257 |
1407 |
Fe3O4@C7 MNPs |
Detection of Uric Acid |
Uric Acid |
Color |
5-250 |
μM |
2.8 |
μM |
|
|
| 6260 |
1410 |
Fe3O4,CaO2@DMSN/C |
Anticancer therapy |
|
|
|
|
|
|
|
|
| 6261 |
1411 |
CeGONRs |
Detection of OPs |
organophosphate |
Color |
0.012-3.5 |
μg/mL |
3.43 |
ng/mL |
|
|
| 6264 |
1414 |
Cu-Ag/g-C3N4/ZIF |
H2O2 detection |
H2O2 |
Color |
0.05-1 |
mM |
2 |
μM |
|
|
| 6265 |
1414 |
Cu-Ag/g-C3N4/ZIF |
Glucose detection |
Glucose |
Color |
0.1-2000 |
μM |
10 |
nM |
|
|
| 6266 |
1416 |
AuNPs@PMo12 |
Acetaminophen detection |
Acetaminophen |
Color |
30-120 |
mg/L |
14.52 |
μg/mL |
|
|
| 6268 |
1418 |
Fe3O4@Poly(L-/D-Trp) |
Nanozymes were used to selectively label live yeast cells among yeast, S. aureus, E. coli and B. subtilis bacterial cells |
|
|
|
|
|
|
|
|
| 6270 |
1420 |
Pt@SiO2@HA nanocomposite |
Immunoassay for histamine |
histamine |
Color |
|
|
0.128 |
mg/L |
|
|
| 6271 |
1421 |
Hemin@MI |
Point-of-care Testing of Pathogenic E. coli O157:H7 |
Escherichia coli O157:H7 (E. coli O157:H7) |
|
100-100000000 |
CFU/mL |
85 |
CFU/mL |
83.13-94.65 |
|
| 6272 |
1422 |
Fe–N–S Co-Doped Porous Carbons |
Bacteria: Sorption Effect |
|
|
|
|
|
|
|
|
| 6273 |
1423 |
Fe3O4@GO |
protect mesenchymal stem cells and promote osteogenic differentiation of rat bone marrow mesenchymal stem cells |
|
|
|
|
|
|
|
|
| 6275 |
1427 |
Cu-CuFe2O4 |
Colorimetric detection of H2O2 |
H2O2 |
|
1.7-60 |
μM |
0.59 |
μM |
|
|
| 6276 |
1427 |
Cu-CuFe2O4 |
Colorimetric detection of GSH |
GSH |
|
2.5-10 |
μM |
0.31 |
μM |
|
|
| 6283 |
1434 |
Au-CDs |
Colorimetric monitoring of Hg2+ |
Hg2+ |
Color |
7–150 |
nM |
3.7 |
nM |
|
|
| 6288 |
1439 |
GOx & AuNCs@ZIF-8) |
Colorimetric sensor for glucose |
Glucose |
Color |
1.0–25.0 |
μM |
0.8 |
μM |
|
|